Recommendations for the Establishment of Stroke Systems of Care: A 2019 Update: A Policy Statement From the American Stroke Association
This article has been corrected.
VIEW CORRECTIONAbstract
In 2005, the American Stroke Association published recommendations for the establishment of stroke systems of care and in 2013 expanded on them with a statement on interactions within stroke systems of care. The aim of this policy statement is to provide a comprehensive review of the scientific evidence evaluating stroke systems of care to date and to update the American Stroke Association recommendations on the basis of improvements in stroke systems of care. Over the past decade, stroke systems of care have seen vast improvements in endovascular therapy, neurocritical care, and stroke center certification, in addition to the advent of innovations, such as telestroke and mobile stroke units, in the context of significant changes in the organization of healthcare policy in the United States. This statement provides an update to prior publications to help guide policymakers and public healthcare agencies in continually updating their stroke systems of care in light of these changes. This statement and its recommendations span primordial and primary prevention, acute stroke recognition and activation of emergency medical services, triage to appropriate facilities, designation of and treatment at stroke centers, secondary prevention at hospital discharge, and rehabilitation and recovery.
To translate advances in scientific knowledge and innovations in clinical care into improvements in patient outcomes, systems must be in place to facilitate optimal healthcare delivery. In acute stroke, scientific knowledge and clinical care have improved in the past 2 decades. In light of these improvements, the American Stroke Association (ASA) first issued policy recommendations for the development of stroke systems of care in 2005.1 A subsequent statement in 2013 issued recommendations on the interactions within stroke systems of care.2 Several other American Heart Association (AHA) and ASA publications continue to provide guidance on improving stroke care.3–8 The past 10 years have witnessed additional gains in knowledge and methods to improve stroke outcomes (eg, extension of intravenous alteplase to 3–4.5 hours, hemicraniectomy, endovascular thrombectomy, telestroke, stroke center certification, mobile stroke units [MSUs], neurocritical care) in the context of significant changes in the organization of healthcare policy in the United States. This statement provides an update to prior publications to help guide policymakers and public healthcare agencies in continually updating their stroke systems of care in light of these changes. This statement and its recommendations span primordial and primary prevention, acute stroke recognition and activation of emergency medical services (EMS), triage to appropriate facilities, designation of and treatment at stroke centers, secondary prevention at hospital discharge, and rehabilitation and recovery.
The public health implications of an optimized stroke system in the United States and worldwide are profound. A system of care that reduces stroke-related deaths by just 2% to 3% annually would translate into ≈20 000 fewer deaths in the United States alone and ≈400 000 fewer deaths worldwide. Reducing poststroke disability would also improve quality of life, reduce costs, and reduce the burden on patients, their families, third-party payers, and governments.
The key components of a modern stroke system of care are outlined here. Operationalizing these elements will vary in different parts of the United States (and the world). However, the general approach and principles should be useful to many healthcare professionals and others involved in such a system.
Burden of Stroke
Someone in the United States has a stroke every 40 seconds, and someone dies of a stroke every 4 minutes.9 About 7.2 million Americans ≥20 years of age have had a stroke.9 Approximately 800 000 people in the United States have a new or recurrent stroke each year.9 Data from 30 239 participants in the REGARDS cohort study (Reasons for Geographic and Racial Differences in Stroke) showed that 22.5% of the population >45 years of age reported stroke symptoms, transient ischemic attack (TIA), or a recent or distant stroke.10 Blacks are more likely to report stroke symptoms than whites.11 Those with lower income and lower education are more likely to report stroke symptoms.9 It is estimated that an additional 3.4 million US adults ≥18 years of age will have had a stroke by 2030, with the highest increase (29%) projected to be in Hispanic men.13 The burden of stroke is borne by both survivors and families/caregivers. Poor quality of life in caregivers is associated with increased rehospitalization and costs of care for the stroke survivor.14 In 2015, the estimated total cost for stroke in the United States was $66.3 billion, and this is projected to increase to $143 billion by 2035.15
Problem Statement
Optimized stroke systems of care that span healthcare delivery from primordial prevention to rehabilitation and recovery can improve communication across patient care domains; identify relevant performance measures and key patient- and system-related outcomes; and provide patients, caregivers, and providers with tools needed for prevention, treatment, and recovery. Adoption of a standardized approach to stroke systems of care in Canada has led to a 15% relative reduction in 30-day in-hospital mortality in acute stroke.16 Implementation of Get With The Guidelines–Stroke at US hospitals has also been associated with an 8% reduction in mortality at 1 year and improved functional outcome at hospital discharge.17 Thus, ineffective systems of care may themselves be a factor associated with worse stroke outcomes and therefore are an important area of focus.
Role of the ASA: Purpose of Statement
The purpose of this statement is to refine and revise the ASA stroke systems of care policy statement and recommendations to reflect the important scientific and clinical advances that have occurred since the last version of this statement.
Key Components of Stroke Systems of Care
Key Stakeholders
Essential for developing a cohesive, aligned regional or state stroke system of care is identifying and engaging all potential stakeholders at the outset. Early incorporation of all stakeholders ensures that the concerns of various groups are considered and addressed before the program is too far along. Often, the absence of a critical stakeholder is recognized during the process, and the concerns of that stakeholder create significant obstacles to moving forward. Fortunately, developing regional stroke systems of care has predicates for these efforts. Similar systems of care have been created to provide optimal regional care for patients with acute myocardial infarction and trauma.18 Drawing from these local programs and incorporating successful components into the stroke system of care can accelerate optimal stroke care models.
Planners of a stroke system of care should consider the term stakeholders in a very broad sense. Stakeholders should draw from key constituents, broadly healthcare providers, patients, caregivers, hospitals, home health companies, regulatory agencies, and payers.19 Healthcare providers should represent the major types of physicians, nurses, and allied health providers who are engaged in the care of stroke patients.20 For acute care systems, important physician specialty stakeholders commonly include emergency physicians, vascular and general neurologists, neurosurgeons, neuroradiologists, neurointensivists, and hospitalists. Important nursing stakeholders include emergency care and neuroscience nurses, speech/language pathologists, and stroke center coordinators. Important allied health stakeholders include paramedics and emergency medical technicians. For prevention systems, important additional physician specialty stakeholders include internists, geriatricians, and cardiologists; additional stakeholders include behavioral psychologists, nutritionists, and urban and regional planners. For rehabilitation and recovery systems, important additional physician specialty stakeholders include physiatrists and neurorehabilitation neurologists. Additional stakeholders include physical, occupational, and speech and language therapists; rehabilitation nurses; social workers; and home health agencies. Hospital representation from across the range of geographic areas within the region and across a broad scope of hospital types should be involved. State and regional health policymakers, including the US Department of Health and Human Services; US Department of Transportation, National Highway Traffic Safety Administration's Office of Emergency Medical Services; Federal Office of Rural Health Policy, Health Resources and Services Administration, US Department of Health and Human Services; and key legislative champions if available, are essential and often lead the process. Rehabilitation personnel, including physiatrists and physical and occupational therapists in collaboration with nurse care coordinators, social workers, and home health agencies, among others, are essential to recovery throughout the continuum. Because there are multifaceted levels of rehabilitation, it is critical that rehabilitation team leaders representing various areas of rehabilitation are included in the system of care development. Patient engagement through either committed individuals or patient advocacy groups ensures that decisions are patient centered. Lastly, hospital administrators, hospital associations, and payers in the region help shape the economic discussions and should contribute to the program. The challenge for organizers is to ensure appropriate representation yet not create a group that becomes too large, unwieldy, and unfocused. Often, it is most efficient to first establish an acute stroke system of care and then expand it to other stroke domains such as access to prevention, public education, and rehabilitation and recovery.
Components of a Stroke System of Care
Primordial/Primary Prevention
Multiple frameworks have been proposed to outline system-based actions taken to improve public health. A visual continuum of the 8 domains of a stroke system of care (as shown in Figure 1) demonstrates how each part affects tertiary disease prevention.21 As an algorithm for the health promotion to disease prevention continuum, opportunities to achieve better health consider not only environmental, cultural, economic, and social influences in a population but also the resources allocated for the provision of public health initiatives. Both cardiovascular disease and stroke are leading causes of death and adult disability.22,23 Thus, they have been the focus of a multitude of national and worldwide primordial and primary prevention causes to reduce the downstream burden of these diseases and the associated lifelong sequelae that affect both patients and families. Stroke systems of care have championed these efforts.
Primordial prevention represents a paradigm shift for integrating resources and policies that target broader at-risk patient populations. Primordial prevention encompasses actions taken to inhibit health risk factors and subsequently to prevent chronic disease in selected or whole communities. Programs that address social conditions (inadequate housing and lack of access to primary care), health behaviors (sedentary behavior, smoking and exposure to smoking), or diet patterns (foods with high fat/high salt content) address the risk for developing hypertension, heart disease, obesity, and stroke from fetal development to older age.24 Primordial stroke prevention has enjoyed the efforts championed by stakeholders that have addressed strategies to reduce hypertension, diabetes mellitus, heart disease, and obesity, all identified as major risk factors for stroke.
Primary prevention refers to the actions addressing established risk factors associated with specific diseases. It includes both population-directed strategies and targeting of individuals with specific risks. Healthcare providers and local and regional programs address commonly known risk factors for chronic disease by either prescribing specific protection measures (prescribing antihypertensives for high blood pressure, prescribing aspirin for patients with stroke risk factors) or promoting healthy behaviors (supporting smoking cessation programs).25–27
Within the past 2 decades, a multitude of local, state, and national campaigns were launched to increase stroke awareness and to reduce stroke burden in communities across the United States. A look back at the success of the US Department of Health and Human Services 2010 Healthy People initiatives shows a reduction in stroke deaths by 23% (from 62 to 42 deaths per 100 000).28 The follow-up Healthy People 2020 initiative aims to improve cardiovascular health of Americans by 20% and to reduce cardiovascular events by 20%.29 The AHA recently prioritized primordial and primary prevention policies for heart disease and stroke by promoting access to healthier (reduced sodium) and less costly foods, improved food labeling, and physical exercise programs in schools and the workplace.24 The US Department of Health and Human Services launched its Million Hearts Program to prevent 1 million heart attacks and strokes through science, quality, and safety programs; partnerships with private sector groups; and public policy and multimedia marketing efforts.30 The AHA published a policy statement to increase awareness of the social determinants of risk factors and outcomes for cardiovascular disease, offering recommendations for research on effective interventions.31
Despite these efforts, gaps remain in the application of many public health practice recommendations to the routine care provided by primary healthcare providers and to the health habits of many individuals in developed and developing countries.
Clinicians, policymakers, and numerous courageous stroke survivors play a key role in supporting the “pyramid base” by promoting programs that prevent the emergence of risk factors for developing disease.32 The 2005 AHA/ASA recommendations for the stroke systems of care task force listed primordial/primary stroke prevention as 1 of 7 required elements of an organized stroke system.1 The 2013 AHA/ASA policy statement on interactions with stroke systems of care included the recommendation that health authorities, including government agencies, support the certification of stroke centers as a valid means to improving patient care and stroke outcomes.2 National campaigns to end stroke (eg, “Target: Stroke” and “Together to End Stroke”) and to consider a lifestyle choice (eg, “Life’s Simple 7”) have become common slogans at health fairs.33–35 Nationally certified acute stroke-ready hospitals (ASRHs), primary stroke centers (PSCs), thrombectomy-capable stroke centers (TSCs), and comprehensive stroke centers (CSCs) are required to engage in community programs that increase stroke awareness, stroke risk factor modification, and lifestyle changes.
A mature local, regional, or national stroke system of care must incorporate primordial/primary prevention. It is important that disparities in access to prevention care be identified and targeted for corrective action. For example, adult blacks are known to be at twice the risk for stroke given that more than half have ≥2 vascular risk factors.11,36 Therefore, more preventive efforts and resources are required for these populations. Data on the prevalence of obesity, diabetes mellitus, and cardiovascular disease reveal that Hispanics and blacks are twice as likely to have any one of these comorbidities that can lead to stroke.37 Several chronic disease care models are currently being tested as a potential solution for improving patient outcomes with cerebrovascular disease.37
Recommendations
1. A stroke system should develop support mechanisms to assist communities and providers in initiating prevention regimens applicable to broader populations. (Unchanged from 2005)
A stroke system should emphasize support tools and measures designed to enhance provider awareness of stroke prevention strategies and current evidence-based treatment recommendations. Providers should be encouraged to and assisted in initiating primordial and primary prevention strategies and in putting in place referral plans that conform to recognized stroke treatment recommendations. Communities are encouraged to use all available resources, including public health departments, to ensure optimal stroke care, and public policy initiatives should support such efforts.
2. A stroke system should develop support mechanisms to assist communities as a whole, patients, and providers in long-term adherence to primordial and primary preventive treatment regimens. (New)
Comprehensive support mechanisms should incorporate multiple strategies that target both providers and patients, and these strategies should take into consideration cultural and geographic customs. Education and practice tools should be developed with health literacy targets appropriate to the linguistic needs and education levels of the targeted population. These frameworks should be designed to support providers in monitoring current stroke prevention recommendations. Useful support tools may include disease management programs and medication adherence interventions.
Community Education and Engagement
A necessary component of integrated stroke systems of care is a commitment to a forum for public awareness and education that spans primordial and primary stroke prevention topics, stroke symptom recognition and response algorithms, and secondary stroke prevention and rehabilitation and recovery strategies. Educational initiatives should target broad age groups, various socioeconomic stations, numerous racial/ethnic demographics, multigenerational families, coworkers across a variety of workplaces, and wide geographic locations. Prevention efforts must involve primary care physicians and advanced practice practitioners. Nontraditional sources of public education and preventive care, such as urgent care centers and emergency departments, should also be engaged because they may be the only points of medical contact for populations with poor access to primary care. Campaigns focusing not only on stroke symptom recognition but also on stroke preparedness, addressing health literacy and cultural tailoring to neurologically underserved communities, have demonstrated considerable promise.
Public awareness campaigns are a popular venue for raising awareness and understanding of various health-related topics. With the approval of alteplase as an acute treatment option for ischemic stroke in 1996 and with the establishment of PSC certification standards in 2003, many efforts on local, regional, and global fronts have occurred over the past decade to promote stroke awareness.33,34,38,39 These efforts have triggered interest in tracking patient-related and system-related outcomes, cultural and behavioral attitudes toward recovery, and public support for further epidemiological and translational research.40
In the United States, ASA public educational and awareness campaigns to reduce the incidence of stroke have been extensive. In 2006, Power to End Stroke was created to reduce stroke and the risk of stroke. It was specifically designed to raise awareness in high-risk communities such as the black population.39 “Stroke’s No Joke” was a public service announcement campaign launched in 2009 to inform blacks about stroke warning signs and the urgency to seek care (by calling 9-1-1).41 Using black stand-up comedians, this campaign addressed cultural competence, racial disease disparities, and social influences that shape relationships between individuals and the medical institutions.41 In an analysis of the 2014 National Health Interview Survey, age-adjusted stroke awareness was 66%, and stroke awareness was lowest for Hispanics, blacks, and those residing in the western United States; the least recognized stroke symptom was sudden severe headache.42 In 2013, the ASA, along with several industry sponsors, launched Together to End Stroke to increase awareness of stroke across the entire continuum of care, including prevention, acute treatment, and poststroke rehabilitation.34 Built into this program was a hip-hop video competition to attract younger members of communities to join the campaign. The effectiveness of each individual campaign is unknown, but the disease-specific campaigns fit within the context of the larger US Department of Health and Human Services Healthy People 2010 and 2020.28,29,33,34,38,39,41
Community-based participatory research is a newer approach to enduring engagement of communities addressing factors limiting positive health behavior. For stroke, prior research has consistently found that although stroke knowledge was important, it was not enough to significantly improve health behavior.43 Other factors limiting an individual’s decision to access health care also likely influence behavior. Several innovative projects have focused on community education to address specific barriers within the stroke system of care. Focused on why patients do not receive timely acute stroke treatments, “Stroke Ready,” a community-academic partnership in Flint, MI, has piloted interventions in the black community to improve stroke preparedness in order to decrease prehospital delay and to increase local stroke treatment rates.44 Using community engagement and partnerships, Stroke Ready increased appropriate stroke responses, including stroke recognition and individuals’ recognition of their own barriers that influence behavior (eg, willingness to call 9-1-1). The ASPIRE project (Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities) in the District of Columbia is another project using a community-engaged approach to stroke preparedness such as decreased stroke presentation times and increased thrombolysis use, targeting underserved black communities.45 To measure improvement in acute treatment rates, large-scale interventions, such as the TLL (Thomas Lewis Latané) Temple Foundation Stroke Project, which was a large community-based grant to improve stroke awareness and treatment in East Texas, or others, are needed to demonstrate the effectiveness of community stroke preparedness interventions.46
There is a recognized need for a new conceptual model for behavioral theoretical interventions for the prevention of stroke. Despite major advances in acute stroke treatment, there remains a mismatch between poor health outcomes for stroke and the high spending on services provided. Stroke is an obvious target for focused interventions because 10 of the stroke risk factors are associated with roughly 90% of the population-attributable risk of stroke around the world across race, ethnicity, sex, and age.47 Current social and behavioral factors leading to risk factors for ischemic and hemorrhagic stroke have been studied, but our current interventions are insufficient to address and implement long-term change. Promising new paradigms based on social cognitive theory are emerging that are patient-centered principles and predictors that may inform and motivate people to adopt healthy lifestyles.48 Once societal organizations and individuals jointly take on accountability for healthy behaviors, potential barriers to implementation and participation can be identified, and then new tools and technology that currently exist and pervade modern society can be brought to bear on this challenging problem.
First, the use of available technology for the passive surveillance and evaluation of patients’ behaviors may be used to establish a baseline and to measure future change. Second, media and social network applications (eg, Facebook, Twitter, Instagram, Snapchat) are all available channels to engage individuals, to increase the visibility of healthy behaviors by role models, and to modify positive or negative reinforcement through posts and sharing. Third, behavioral economics (ie, the study of how individuals make successful and unsuccessful attempts to pick best options) and gamification to alter behavior (eg, use of pedometers or calorie devices to challenge individuals and groups toward positive healthy behavior) are novel strategies that should be considered in policy change. The availability of social cognitive theory and the emergence of pervasive digital tools offer tremendous opportunity for future medical behavioral interventions.40
These ongoing activities represent advances in the efforts of stroke systems to integrate existing and novel educational initiatives to improve public education focused on stroke symptoms, treatment options, and specifically how rapid care can significantly increase the percentage of patients eligible for acute reperfusion therapies. In the future, local, regional, and national stroke systems must expand such efforts to the entire continuum of stroke care from primordial prevention through recovery. Recognition of the historical barriers to stroke education, underserved at-risk populations, novel educational methodology, and existing social media technology may allow more enduring changes in behavioral responses to both individual and community stroke knowledge.
Recommendations
1.
A stroke system should support local and regional educational initiatives to increase stroke awareness (including stroke warning signs, risk factors, primary and secondary prevention, and recovery), aimed at the general population with enriched targeting of populations at increased risk for stroke and poor outcomes after stroke. (New)
2.
A stroke system should monitor the effectiveness of community education in improving behavioral responses to warning symptoms, stroke treatment rates, mortality, and other relevant outcomes. (New)
3.
Methods to systematically identify and treat risk factors in all patients at risk for stroke should be developed. (New)
4.
Innovative behavioral interventions addressing barriers to healthy behaviors, prevention adherence, and warning sign action with tools such as digital phenotype analysis, social network analysis, gamification, and machine learning offer opportunity for sustainable behavioral change, and research in these areas should be encouraged. (Revised from 2005)
Emergency Medical Services
Currently, only ≈50% to 60% of hospitalized stroke patients arrive at the hospital via EMS.49–51 Racial/ethnic minorities are less likely to use EMS.52 Given poor stroke awareness among US adults, with the lowest awareness among Hispanics and blacks,42 lack of knowledge of the risk factors and of the signs and symptoms of stroke remains a hindrance to timely stroke care. After EMS is activated, limitations in the accuracy of prehospital stroke assessment tools and in the timeliness of prehospital care to facilitate access to appropriate hospital care persist.
Prehospital Stroke Screening Tools
Prehospital stroke screening tools remain an important aspect of stroke care. In an Italian study of 18 231 EMS dispatches for stroke-like symptoms, the positive predictive value of the dispatch stroke/TIA symptoms being confirmed on scene by EMS providers was 34.3% (95% CI, 33.7%–35.0%; 6262 of 18 231), and the sensitivity was 64.0% (95% CI, 63.0%–64.9%; 6262 of 9791). Centers that used the Cincinnati Prehospital Stroke Scale (CPSS) more often (ie, >10% of cases) had higher sensitivity (71% [95% CI, 87%–89%] vs 52% [95% CI, 51%–54%]).53 In a systematic review of prehospital stroke scales performed by EMS providers in the field, both the CPSS (area under the curve, 0.813) and the Los Angeles Prehospital Stroke Screen (area under the curve, 0.964) showed better performance than 5 other field stroke recognition scales.54 The Los Angeles Prehospital Stroke Screen performed more consistently, but the CPSS had similar diagnostic capability. Of 184 179 US EMS transports with primary impressions of stroke, only 46% met the recommended on-scene time of <15 minutes.55 Furthermore, hospital prenotification occurs in only 67% of EMS transports.50 Thus, stroke systems of care should endeavor to enhance recognition of stroke symptoms by dispatch and EMS providers, to reduce on-scene time in transported patients, and to improve prenotification of the receiving hospital.
Prehospital Stroke Severity Scales and Rerouting of Patients
With the advent of thrombectomy for acute ischemic stroke with large vessel occlusion (LVO) of the internal carotid artery and middle cerebral artery stem (M1) and worse outcomes with delays to thrombectomy,56,57 ensuring that EMS providers transport patients with acute neurologic deficits to the right hospital for the best treatment as quickly as possible is increasingly critical. At least 6 stroke severity scales targeted at the recognition of LVO in the prehospital setting to facilitate transfer to thrombectomy centers have been published.58–63 However, all the scales were initially derived from data sets of confirmed stroke cases or selected prehospital cases. Three of the current scales have been tested in the prehospital setting in a limited fashion and without head-to-head comparisons.64–66 The Cincinnati Stroke Triage Assessment Tool, Rapid Arterial Occlusion Evaluation, Los Angeles Motor Scale, and Field Assessment Stroke Triage for Emergency Destination are specifically named on the AHA Mission: Lifeline severity-based stroke triage algorithm for EMS.67
For prehospital patients with suspected LVO by a stroke severity scale, the Mission: Lifeline algorithm recommends direct transport to a CSC if the travel time to the CSC is <15 additional minutes compared with the travel time to the closest PSC or ASRH. At this time, there is insufficient evidence to recommend 1 scale over the other or whether the proposed 15-minute specific threshold of additional travel time for bypass of a PSC or ASRH is optimal. Given the known impact on outcomes of every 15-minute delay of intravenous alteplase,68 the known impact of delays to thrombectomy,57 and the anticipated delays in transport for thrombectomy in eligible patients originally triaged to a nonendovascular center, the Mission: Lifeline algorithm is a reasonable approach. Further research is warranted, and prehospital algorithms will need to be updated periodically as new evidence emerges.
MSUs and Prehospital Telemedicine
In the past few years, MSUs have emerged as an innovative approach to facilitating timely stroke care.69 MSUs are computed tomography (CT)–equipped ambulances that are staffed with a nurse and paramedic, with or without an onboard physician. MSUs without a physician onboard may be supported by a physician available via telemedicine.70 Ischemic stroke patients may be treated in the prehospital setting with intravenous alteplase, with 31% of subjects treated within the “golden hour” compared with 4.9% in routine care, although this has not been associated with improved outcomes in published reports.71 Hemorrhagic stroke patients may be identified by CT on the MSU and triaged to an appropriate facility.
Although MSUs have been proliferating in the United States and elsewhere, challenges exist.72 The implementation and sustaining costs without an established means of reimbursement from the government or third-party payers currently preclude widespread use. At this time, there is insufficient evidence to recommend wide-scale deployment of MSUs. Therefore, ongoing studies should address clinical utility, generalizability constraints, and cost-effectiveness. Further research is warranted, and integration of MSUs into prehospital algorithms will need to be updated periodically as new evidence emerges.
Recommendations
1.
Public health leaders along with medical professionals and others should design and implement public education programs focused on stroke systems and the need to seek emergency care (by calling 9-1-1) in a rapid manner. These programs should be repetitive and designed to reach diverse populations. Further research is needed to establish the most effective programs for diverse populations. (New)
2.
EMS leaders, in coordination with local, regional, and state agencies and in consultation with medical authorities and local experts, should develop triage paradigms and protocols that ensure that all patients with a known or suspected stroke are rapidly identified and assessed with a validated and standardized instrument for stroke screening such as FAST (Face, Arm, Speech, Time), Los Angeles Prehospital Stroke Screen, or CPSS. (Revised)
a. In prehospital patients who screen positive for suspected stroke, a standard prehospital stroke severity assessment tool (eg, Cincinnati Stroke Triage Assessment Tool, Rapid Arterial Occlusion Evaluation, Los Angeles Motor Scale, and Field Assessment Stroke Triage for Emergency Destination) should be used to facilitate triage. In the absence of new data, it is reasonable to adapt the Mission: Lifeline algorithm to the needs of the community. Further research is needed to establish the most effective prehospital stroke severity triage scale, which may be one of the published scales or a novel scale or device. (New)
b. Standardized approaches to prehospital stroke assessment, triage, and management should be encouraged for 9-1-1 call centers and EMS dispatchers. Further research is needed to establish the most effective programs for stroke recognition by 9-1-1 call centers and EMS dispatchers. (New)
3.
When there are several intravenous alteplase–capable hospitals in a well-defined geographic region, extra transportation times to reach a facility capable of endovascular thrombectomy should be limited to no more than 15 minutes in patients with a prehospital stroke severity scale score suggestive of LVO. When several hospital options exist within similar travel times, EMS should seek care at the facility capable of offering the highest level of stroke care. Further research is needed to establish travel time parameters for hospital bypass in cases of prehospital suspicion of LVO. (New)
a. Protocols that include prearrival notification by EMS that a stroke patient is en route should be used in all cases. (New)
Hospital-Based Acute Stroke Management
Given recent advances in the management of acute ischemic stroke, hospital-based acute stroke treatment must involve efficient processes of care to ensure the timely identification of stroke patients who may benefit from the effective delivery of thrombectomy by qualified providers in the right hospital. Furthermore, cases of large hemispheric or cerebellar ischemic stroke and hemorrhagic stroke, including aneurysmal subarachnoid hemorrhage (SAH), arteriovenous malformations, and spontaneous intracerebral hemorrhage (ICH), must be managed in hospitals with dedicated neurosurgical and neurointensive care services. With this recognition, a 3-tier system of hospital certification has emerged in stroke systems of care over the past 20 years. Recent advances have led to further refinement of stroke hospital systems to include the additional designation of TSCs. In the next sections, we discuss current hospital certification, recent advances in hospital-based stroke management, and emerging solutions to the implementation of scientific advances in routine clinical practice.
Hospital Certification
The Joint Commission, DetNorske Veritas, Healthcare Facilities Accreditation Program, and state health departments across the United States typically designate 3 levels of hospital certification for the management of acute stroke. Terminology varies, but here we use CSC, PSC, and ASRH to represent the highest to lowest level of stroke readiness. All levels of stroke centers should work within their region in an integrated fashion, providing and sharing best practice. Participation in quality improvement processes such as Get With The Guidelines facilitates continuous improvements in care at stroke centers. The ASRH designation is intended to recognize smaller, perhaps remote, community hospitals that have established processes for acute stroke evaluation and treatment, including telemedicine, and well-developed protocols to ensure rapid transfer of stroke patients who require care at higher-level centers to those facilities. ASRHs were created to address gaps in care in regions without PSCs or CSCs but where optimized emergency stroke care can be delivered with guidance from regional PSCs and CSCs. PSCs have efficient processes for the clinical diagnosis of ischemic stroke, safe and timely administration of intravenous alteplase, secondary diagnosis of stroke pathogenesis, and screening for downstream complications. In addition, PSCs provide this care in the context of a defined stroke unit. There are differences in stroke quality of care by certifying organization. An analysis of 477 297 acute ischemic stroke admissions from 977 certified PSCs (74% The Joint Commission, 4% DetNorske Veritas, 1% Healthcare Facilities Accreditation Program, and 21% state based) found that quality was generally similar among the 4 groups, but the rates of alteplase use were higher in The Joint Commission– and DetNorske Veritas–certified hospitals (9.0% and 9.8%) and lower in state-certified and Healthcare Facilities Accreditation Program–certified hospitals (7.1% and 5.9%). Door-to-needle times were significantly longer in Healthcare Facilities Accreditation Program hospitals. State PSCs had higher in-hospital mortality compared with The Joint Commission–certified PSCs.73 A new level of care has recently been identified to address the need for greater access to thrombectomy in the community: the TSC. This tier sits between a PSC and a CSC. The proper role of TSCs in communities without any access to thrombectomy is straightforward; its role in a community that already has access to a CSC is more controversial, and routing plans for patients with suspected LVO should always seek the center of highest capability when interfacility travel time differences are short. In the United States, there are currently at least 1500 PSCs, ≈200 CSCs, and a growing number of ASRHs. Care at certified stroke centers is associated with improved patient care and outcomes.16
CSCs provide the full complement of stroke neurology, critical care, and neurosurgical personnel and infrastructure to manage the most complex ischemic and hemorrhagic stroke patients (Table 1). These tertiary and quaternary facilities serve as centralized centers within mature stroke systems and leverage known volume-outcome relationships in cerebrovascular disease.74 It remains unknown what impact the new TSC designation will have on thrombectomy experience at the proposed TSCs and current CSCs. Although the total number of cases is expected to increase, insufficient total cases per hospital may dilute local experience and adversely affect patients because volume of cases is well known to be associated with improved performance.75,76
ASRH | PSC | TSC | CSC | |
---|---|---|---|---|
Location | Likely rural | Likely urban/suburban | Likely urban | Likely urban |
Stroke team accessible/available 24 h/d, 7 d/wk | Yes | Yes | Yes | Yes |
Noncontrast CT available 24 h/d, 7 d/wk | Yes | Yes | Yes | Yes |
Advanced imaging (CTA/CTP/MRI/MRA/MRP) available 24 h/d, 7 d/wk | No | Yes | Yes | Yes |
Intravenous alteplase capable | Yes | Yes | Yes | Yes |
Thrombectomy capable | No | Possibly | Yes | Yes |
Diagnoses stroke pathogenesis/manage poststroke complications | Unlikely | Yes | Yes | Yes |
Admits hemorrhagic stroke | No | Possibly | Possibly | Yes |
Clips/coils ruptured aneurysms | No | Possibly | Possibly | Yes |
Dedicated stroke unit | No | Yes | Yes | Yes |
Dedicated neurocritical care unit/ICU | No | Possibly | Possibly | Yes |
ASRH indicates acute stroke-ready hospital; CSC, comprehensive stroke center; CT, computed tomography; CTA, computed tomography angiography; CTP, computed tomography perfusion; ICU, intensive care unit; MRA, magnetic resonance angiography; MRI, magnetic resonance imaging; MRP, magnetic resonance perfusion; PSC, primary stroke center; and TSC, thrombectomy-capable stroke center.
Endovascular Thrombectomy
Multiple randomized clinical trials demonstrated the primacy of rapid thrombectomy with or without intravenous alteplase (depending on alteplase eligibility) for achieving functionally independent outcomes in eligible acute ischemic stroke patients with LVO.77–81 Furthermore, recent data from 2 extended-window trials indicate that additional patients who are selected with advanced imaging criteria within the 6- to 16-hour or 6- to 24-hour window of last known normal also benefit from thrombectomy.82,83 Therefore, stroke systems of care should be organized to identify thrombectomy-eligible patients and to deliver such patients to the appropriate hospital in a timely manner, and these hospitals should have processes in place to ensure that thrombectomy-eligible patients are identified and treated quickly and effectively after arrival.
Decompressive Hemicraniectomy
Patients with large completed middle cerebral artery strokes benefit from early decompressive hemicraniectomy. The experience of Schwab et al,84 the systematic review by Gupta et al,85 the DESTINY trial (Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery),86 and the DECIMAL trial (Decompressive Craniectomy in Malignant Middle Cerebral Artery Infarction)87 all emphasize the importance of early intervention in maximizing clinical benefit. Data now support both a mortality and functional outcome benefit associated with this intervention. Systems of care must therefore account for the availability of qualified neurocritical care and neurosurgical providers to provide this proven intervention in a timely manner.
Hemorrhagic Stroke
Both SAH and ICH may be associated with life-threatening intraventricular hemorrhage, obstructive hydrocephalus, and intracranial hypertension early in the clinical course. Early placement of an intraventricular catheter for cerebrospinal fluid diversion can be lifesaving. Emergency decompression of cerebellar hemorrhage can also be lifesaving. Thus, transfer of these patients to nonneurosurgical hospitals can be devastating. Furthermore, for aneurysmal SAH (aSAH), surgical clipping or endovascular coiling of the ruptured aneurysm as soon as possible is warranted to reduce the risk of rebleeding. Low-volume hospitals (eg, <10 aSAH cases per year) should facilitate transfer of patients with aSAH to high-volume centers (eg, >35 aSAH cases per year) with experienced cerebrovascular surgeons, endovascular specialists, and multidisciplinary neurocritical care services.88 For ICH, management at high-volume centers with neurosurgical and neurocritical care has been associated with reduced mortality.89 Stroke systems of care should ensure that patients with SAH and ICH are cared for at high-volume hospitals capable of ensuring optimized outcomes for these patients, typically hospitals with CSC certification.
Current Challenges, Barriers, and Opportunities
Currently, there is uncertainty about the best thresholds for quality metrics for prehospital recognition of potential patients with LVO (eg, acceptable overtriage rates) and accepted time metrics (eg, door in–door out and PSC puncture to CSC puncture) for patients with LVO triaged to nonthrombectomy centers. “Ideal” times have been proposed.90 DAWN (Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo) and DEFUSE 3 (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3) used various methods of advanced imaging (beyond a simple noncontrast head CT) to identify thrombectomy-eligible patients up to 24 hours since last known normal.82,83 Although larger hospitals may have the ability to obtain and interpret these images 24 h/d and 7 d/wk, smaller underresourced hospitals may have challenges in obtaining and interpreting these images in a timely fashion. A recent small study suggests that early stroke team activation, CT angiography performed in <30 minutes, and cloud image sharing may reduce door in–door out time and facilitate rapid treatment.92 Future efforts should be aimed at supporting the widespread implementation of rapid advanced imaging to detect LVO in appropriately selected patients.
Overall, current opportunities for continuing to improve acute stroke care include the following: (1) public education to ensure the patients and families are aware of differences in hospital capabilities; (2) establishment of best practices that ensure that low-volume/inexperienced centers have processes in place to facilitate transport to more experienced centers or to ensure optimized care for patients who may be appropriately retained at the low-volume center; (3) prehospital assessment tools to allow effective identification and triage among levels of care; (4) accepted training standards for the certification of qualified interventionalists to provide thrombectomy; (5) ensuring an adequate supply of qualified interventionalists; (6) existing capital infrastructure and imaging capabilities at centers currently caring for stroke patients; and (7) development of and transparent sharing of processes of care and outcomes, depending on the capabilities of the center and allowing for appropriate risk adjustment and comparison.93,94
Emerging Solutions
The CSC, TSC, PSC, and ASRH certification standards provide a strong platform for the introduction of data-driven improvements in hospital-based acute stroke care. Increased participation in these processes or mirroring by local, county, and state systems would foster improved process and outcome quality. Establishing evidence-based acceptable prehospital overtriage rates and treatment/transfer time metrics at nonthrombectomy centers, coupled with technical angiographic results and procedural complication profiles, could reproduce previous successes in PSC networks for stroke, ST-segment–elevation myocardial infarction networks for myocardial infarction, and American College of Surgeons Verification, Review, and Consultation Program.
Access and Workforce for Acute Stroke Thrombectomy in the United States
An estimated 27 000 to 97 000 patients may be eligible for thrombectomy annually in the United States.95 Access to acute stroke intervention for patients with LVO in the United States has evolved in the past decade. In 2011, 56% and 85% of the US population had access to endovascular thrombectomy-capable hospitals within an hour by ground and air, respectively.96 Recent modeling data, with an assumption of the addition of 5 to 20 optimally located CSCs per state, estimate that 63% of the US population would have ground access to thrombectomy centers within an hour and 83% would have ground/air access within an hour.97 Furthermore, workforce demand-supply for thrombectomy is in a rapid state of evolution. Figures 2 and 3 show the geographic dispersion in the United States to thrombectomy-capable and endovascular-capable centers.
The Committee on Advanced Subspecialty Training of the Society of Neurological Surgeons has undertaken the certification of neuroendovascular training programs in conjunction with the Society of NeuroInterventional Surgery and the Society of Vascular and Interventional Neurology.98 These standards represent the collaborative efforts of neurological surgery, interventional neuroradiology, and interventional neurology in adopting uniform standards and complement previous guidelines by the Accreditation Council for Graduate Medical Education.99 Over time, these standards will provide a more uniform set of expectations for endovascular performance. More data are needed for monitoring evolutions in access to care and available workforce to facilitate such access.
Recommendations
1.
The CSC, PCS, TSC, and ASRH framework provides an appropriate platform for the data-driven development of hospital-based processes of care and outcome metrics. All certification systems should meet or exceed these standards. All levels of stroke centers should work within their region in an integrated fashion, providing and sharing best practice. (New)
a.TSC is a new hospital designation. Evidence supporting timely identification and treatment of thrombectomy-eligible ischemic stroke patients at TSCs is warranted. TSC treatment processes, technical outcomes (reperfusion rates), complications, and patient clinical outcomes should be tracked and reported.
b. Both the clinical benefit of decompressive craniectomy and the management of hemorrhagic stroke merit systems consideration of neurosurgical and neurocritical care resources in developing comprehensive systems for high-acuity stroke patients.
2.
Identification of candidates for thrombectomy requires the timely completion of parenchymal and arterial imaging (CT or magnetic resonance) to identify the subset of patients who may benefit from thrombectomy. All centers managing stroke patients should develop a plan for the definitive identification and treatment of these patients. Hospitals without thrombectomy capability should have transfer protocols to allow the rapid treatment of these patients at hospitals with the appropriate level of care. In some instances (eg, rural facilities without imaging and radiology capabilities 24 h/d and 7 d/wk), this may mean rapid transfer of patients with clinically suspected LVO to hospitals where their workup may be expedited. (New)
3.
Centers providing thrombectomy should rigorously track patient flow at all time points from presentation to imaging to intervention to allow iterative process improvement. Technical outcomes (reperfusion rates), procedural complications, and patient clinical outcomes must be tracked and reported. (New)
4.
Data suggest the benefit of more sophisticated imaging triage that assesses penumbral pattern in selecting patients for endovascular thrombectomy from 6 to 24 hours from last known normal. These data merit the broader adoption of this imaging technology in thrombectomy centers. (New)
5.
Certification standards for endovascular training programs and individuals provide a means for monitoring the adequacy and qualification of the endovascular workforce. The TSC designation adds new structure, monitoring, and transparency for the requirements for stroke neurointerventionalists.
Secondary Prevention/Postacute Care
The postacute period of the stroke continuum is critical because of the importance of early rehabilitation to enhance recovery, improved transitions of care to reduce readmission, and early follow-up to continue and refine secondary prevention to reduce recurrent stroke risk. Secondary prevention of stroke has improved over the past 5 decades, mostly as a result of improved use of antithrombotic therapy and blood pressure management.100 Since the previous publication, inpatient quality measures have been instituted that are required by all hospitals for public reporting purposes. This has resulted in a more standardized approach to subacute stroke care, and adherence to these measures has improved over time.101 For postacute stroke, the Centers for Medicare & Medicaid Services (CMS) mandated all-cause 30-day readmissions penalties for hospitals that exceed the national risk-adjusted readmission rate in 2016.102 Recent evidence has shown that a small proportion of readmissions are preventable103 and that some planned readmissions may be warranted but still are penalized according to the CMS definition.104 Advocates for further refinement of the determination of 30-day readmission rates (and other quality measures) are concerned that the calculation of readmission rates without initial stroke severity (ie, the National Institutes of Health Stroke Scale) will lead to misclassification of hospital performance and therefore misappropriation of resources.93 Although the focus of processes to reduce readmissions has been on hospital-related factors, the social, functional, and community determinants of health are likely to be factors important in later (>7 days after discharge) readmissions that appear to be unrelated to hospital quality.105 Given the uncertain impact of making changes to processes of care to reduce readmissions, the focus of postacute care should be on reducing mortality, maximizing recovery, and preventing recurrent stroke and cardiovascular events.
A comprehensive pathway for stroke care called the Global Stroke Services Action Plan was published in 2014.106 This action plan is inclusive of the US stroke quality measures but is more extensive because it covers stroke care across the continuum. For transitions of care, the action plan recommends, “Patients, families, and informal caregivers should be provided with information, education, training, emotional support, and community services specific to the transition they are undergoing.”106 Although this practice is likely commonly achieved in the inpatient rehabilitation setting before discharge, it is less common on discharge from the acute hospital setting, where the length of stay may be ≤4 days.
Despite the progress that has been made in the past 10 years, there are still gaps in and challenges and barriers to improving postacute care and secondary prevention. One of these barriers is the lack of structure in the paths that stroke patients and caregivers experience. An important aspect of postacute specialized care is screening for and avoiding stroke complications, which can include falls, venous thromboembolism, recurrent stroke or TIA, extension of an existing infarct, hypotension/hypertension, infections, cardiac complications, dehydration, and renal failure. Although some of these complications are addressed in the hospital with current quality metrics, there are no US hospital measures of the quality of postacute care designed to reduce these complications and to ensure that secondary prevention is followed after discharge. However, the Global Stroke Services Action Plan provides an evidence-based framework for hospitals to meet these specific quality indicators.106
Access to postacute stroke services is another major barrier to equitable outcomes after stroke. There is wide geographic variation in access to postacute services for stroke patients, particularly postacute facilities and home health care.107 A study of contemporary trends from 2003 to 2011 showed that overall 44% of patients are discharged home without any postacute services.108 Alarmingly, 65% of stroke survivors <65 years of age were discharged without any postacute care services.108 In addition, geographic disparities have been assumed to affect the quality of stroke prevention. However, the designation as a health professional shortage area was not associated with statin use, as shown in the REGARDS study. In fact, the lack of insurance appeared to decrease the likelihood of adequate access to stroke prevention medications, not designation as a health professional shortage area region alone.109 The variation in access to services based on insurance (or lack thereof) and age <65 years suggests that many patients who should receive services are denied access, and this could have a significant negative effect on both recovery and secondary prevention.
Stroke education is an essential part of the postacute transition and includes not only what to do if stroke symptoms recur but also how to manage stroke risk factors; medications; appointments for primary care, specialists, and therapy; home safety; and lifestyle changes. Stroke education at discharge is a quality measure and publicly reported. However, stroke education in the postacute transition is even more important because of the overwhelming amount of information that patients and caregivers receive during their hospital stay and the information needed to adapt to the community.110 A recent scoping review of postacute services for patients with mild stroke concluded that services that provide education related to maximizing participation in secondary prevention is an area (among several) that requires more development and assessment in this population.111
Emerging solutions to these challenges and barriers are on the horizon. A model of transitional care provided by a trained stroke nurse practitioner and a registered nurse showed that a systematic assessment of stroke complications reduced 30-day readmissions.112 After adjustment for important confounders, being seen in this specialized transition clinic was associated with a nearly 50% reduction in 30-day readmissions compared with not being seen there.112
Early supported discharge is another model of transitional care in which patients are discharged home early and receive rehabilitation and specialized stroke services from a hospital-based multidisciplinary team that includes physical and occupational therapists, nurses, a social worker, a stroke neurologist, and personal aides.113 An important premise of early supported discharge is the use of community services. Stroke systems of care should be connected not only with outpatient therapy and home health care but also with other services that can support patients and caregivers and allow sustained improvement,114 similar to the recommendations of the Global Stroke Action Plan.106 These services include community exercise programs, fall prevention programs, behavioral health, pharmacy services, stroke/caregiver support groups, risk factor self-management, local agencies that provide nutrition and transportation services (such as provided by the Area Agency on Aging), and handoffs to primary care.113
A new model of care that includes a patient-centered approach to both postacute care and secondary prevention is the Comprehensive Post-Acute Stroke Services model, currently being compared with usual care in 41 hospitals across North Carolina in a cluster-randomized pragmatic clinical trial.115 This model screens for postacute complications but also assesses the medical, social, and functional determinants of health and provides each patient with an individualized care plan that includes only the services needed for that patient at the point of care. A unique facet of this program involves the development of a community resource network located at each hospital participating in the trial, so that services can be mapped to a patient on the basis of what is available to that patient locally. The primary outcome of this trial is functional status, but rates of 30-day readmissions and multiple aspects of secondary prevention will also be determined.
The use of community health workers is also an emerging trend in healthcare services in the United States. In a systematic review of 34 published studies, the overall impact of community health worker intervention was variable, but 5 randomized trials showed a significant reduction in ≥1 emergency department visits, hospitalizations, or urgent care visits.116 The ongoing SUCCEED trial (Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities) will provide evidence for the use of an advanced practice clinician–community health worker team for secondary prevention after stroke.117
Recommendations
1.
Stroke centers should use organized approaches (eg, stroke teams, stroke units, and written protocols) to ensure that all patients receive appropriate subacute care. (Revised from 2005)
2.
Stroke centers should adopt approaches to secondary prevention that address all major modifiable risk factors and that are consistent with the national guidelines for all patients with a history or a suspected history of stroke or TIA. The focus of postacute care should be on reducing mortality, maximizing recovery, and preventing recurrent stroke and cardiovascular events. (Revised from 2005)
3.
A stroke system should establish support systems to ensure that all patients discharged from hospitals and other facilities to their homes have appropriate follow-up with specialized stroke services when needed and primary care arranged on discharge. These efforts should include education and training for the patient and his or her family members. Clear, comprehensive, and timely communication across the inpatient and outpatient poststroke continuum of care is essential to ensure appropriate medical and rehabilitation care. (New)
4.
To standardize postacute care after stroke discharge, stroke centers should comprehensively screen for postacute complications, provide individualized care plans for patients during the transition of care, provide referrals to community services, and reinforce secondary prevention and self-management of stroke risk factors and lifestyle changes to decrease the risk of recurrent stroke. Trained stroke nurses, nurse practitioners, social workers, community health workers, and others should play a pivotal role. (New)
Rehabilitation and Recovery of Stroke Survivors
Rehabilitation remains the primary means by which a stroke survivor recovers maximal function. As shown in Table 2, stroke rehabilitation and recovery occur in various care settings.119
Location | Patient Population | Services Offered |
---|---|---|
Inpatient rehabilitation facility | Need close medical supervision | Hospital-level care directly supervised by a physician |
Able to participate in at least 3 h of therapy per day 5 d/wk (or, in certain cases, at least 15 h of therapy within consecutive 7-d periods) | Physical, occupational, and speech therapy | |
Not expected to need institutional care | Specialized nursing and social services | |
Skilled nursing facility | Need skilled nursing care | Rehabilitation nursing on site |
Able to participate in therapy for <3 h/d up to 5 d/wk to improve functional ability | Care plan provided by a physician | |
Occupational, speech, physical, and other therapy as needed | ||
Long-term acute care hospital | Have multiple chronic conditions | Extended comprehensive rehabilitative services |
Need hospital-level care for an average of ≥25 d | Highly specialized medical care | |
Nursing home | Do not require skilled nursing | Long-term care for patients who cannot live independently |
Outpatient clinic | Do not require inpatient care | Hospital-based or free-standing sites |
Able to leave home for therapy | Transition of care to primary care provider | |
Occupational, speech, and physical therapy | ||
Home health agency | Must be homebound except for medical appointments | Transition of care to primary care provider |
Skilled nursing | ||
Occupational, speech, and physical therapy | ||
Health aide | ||
Social services |
The Commission on Accreditation of Rehabilitation Facilities developed a Stroke Specialty Program that encompasses inpatient, outpatient, home and community, residential, and pediatric rehabilitation programs. Standards seek to minimize impairments, secondary complications, and environmental barriers; to reduce activity limitations; to maximize participation and quality of life; and to prevent recurrent stroke. The Joint Commission Disease-Specific Care Certification in Stroke Rehabilitation uses performance improvement to identify and address improvement opportunities, implements and graphically depicts a performance plan over time, and reviews the effectiveness of the interventions implemented in response to improvements identified by measurement activity.
Practice guidelines for stroke rehabilitation are well established and recommend that stroke survivors receive rehabilitation at an intensity commensurate with anticipated benefit and tolerance.118 However, access to rehabilitation services remains a major barrier. Availability of postacute care settings (especially in underserved areas), prospective payment variability, regulatory practices, the pressure to discharge patients rapidly from acute care, race, ethnicity, and sex all may influence if and where rehabilitation services are provided.107,120–126 Uninsured stroke survivors may remain in acute care longer because of problems in transferring them to inpatient rehabilitation settings.127 Thus, it is not surprising that a recommendation from the “Interactions Within Stroke Systems of Care” policy statement emphasizes that “…all patients have access to post-stroke care (discharge planning services, rehabilitation, nursing facilities, medical follow-up) regardless of their financial status or socioeconomic background.”2
How stroke survivors are assessed for rehabilitation may also be problematic. Although PSC standards require that stroke survivors be assessed for rehabilitation services, 60.4% of stroke survivors <65 years of age and 37.5% of those ≥65 years of age were discharged home without rehabilitation services between 2003 and 2011.108 There are many reasons for this phenomenon. Providers may be tempted to use no measurable deficits on the National Institutes of Health Stroke Scale as a guide to determine the need for rehabilitation services, but stroke survivors scoring a zero on the National Institutes of Health Stroke Scale may exhibit discernible motor deficits on the upper limb Fugl-Meyer and the Arm Motor Ability Test,128 as well as truncal ataxia, headache, vertigo, and nausea after posterior circulation strokes.129 Thus, standardized neurological, functional, and psychosocial assessments are needed to ensure that these and other issues are not missed.
Finally, a single dose of postacute rehabilitation does not meet the needs of all stroke survivors. Sufficient evidence has demonstrated that chronic stroke patients benefit from additional rehabilitation therapy.130,131 Existing models of the prediction of rehabilitation potential explain less than half of the variance in recovery after stroke.132 Thus, stroke survivors need to be assessed functionally throughout their lifetimes to prevent readmission, to maintain fitness, and to prevent secondary complications.133
Recommendations
1. A stroke system should ensure that all stroke survivors receive a standardized screening evaluation during the initial hospitalization to determine whether rehabilitation services are needed and the type, timing, location, and duration of such therapy. Long-term primary care and specialist (physiatrist or neurology) follow-up should be arranged to identify patients with residual impairments so that these patients receive appropriate continued rehabilitation. (New)
The use of a standardized evaluation provides important insights into the type and duration of rehabilitation therapy needed on a patient-by-patient basis. Evaluations for stroke rehabilitation should include a neurological assessment of residual deficits; an assessment of functional (activities of daily living), cognitive, and psychological status; and determination of previous functional status and medical comorbidities, the level of family/caregiver support, the likelihood of returning to community living, and the ability to participate in rehabilitation services.
2. A stroke system should periodically assess its level of available rehabilitation services and community resources. (New)
Such an assessment should include the total number and types of beds available, the intensity of services provided in different settings, the presence of interdisciplinary coordinated teams, including the use of community health workers, and the adequacy of care coordination programs. This assessment should consider the current and future needs in the system for inpatient and outpatient care, including the relative mix among inpatient rehabilitation facilities, skilled nursing facilities, continuing-care retirement communities, home care services, and outpatient services.
3. A stroke system should establish support systems to ensure that patients discharged from hospitals and other facilities to their homes have appropriate follow-up and primary care arranged on discharge. (New)
The stroke system should ensure that patients are referred to the setting most appropriate to their clinical needs.
Palliative and End-of-Life Care
Of the nearly 800 000 reported strokes per year, ≈16% of patients will die of their stroke within the first 30 days. Of the nearly 6 million Americans who have survived a stroke, ≈30% are left with permanent disabilities. Given the serious and complex challenges they face, stroke survivors and their caregivers can benefit from palliative care that can be provided at any level of stroke care and optimizes quality of life throughout the continuum of stroke care by reducing suffering, promoting comfort, and preserving dignity. Therefore, the 2014 AHA/ASA scientific statement that addresses palliative and end-of-life care in stroke emphasizes that palliative care has much to offer when stroke care is clinically challenging and emotionally intense and when ethically complex medical choices are encountered.134 Palliative care is not an alternative to offering life-sustaining therapies but supplements and enhances care delivery for stroke survivors, caregivers, and providers alike when facing serious illness.134
Special Considerations
Telemedicine
Over the past decade, telestroke consultation has flourished and spread worldwide. Several publications by the AHA and others have summarized the evidence supporting telestroke and addressed the value and cost-effectiveness of telestroke in enhancing access to care within a stroke system of care.4,135,136 Telestroke has been shown to increase rates of thrombolysis, particularly at hospitals without stroke units, without increasing the rates of adverse events compared with patients treated initially at tertiary care stroke centers.137,138 Approximately 25% of thrombolysis in the United States in the Get With The Guidelines–Stroke registry occurs in a drip-and-ship model, and a large proportion of this activity is likely supported by telestroke consultation.139 Telestroke also plays an important role in cerebrovascular care beyond ischemic stroke and thrombolysis decision making. Telestroke networks, as part of a stroke system of care, may help shorten hospital length of stay through advanced care, avoid a large number of unnecessary transfers, identify specific stroke patients who require urgent interventions or surgery (eg, patients with aSAH, those with intraventricular hemorrhage, candidates for craniectomy, or patients with LVO), establish stroke units and stroke teams in spoke hospitals, and eradicate disparities by delivering expertise where it is needed, whether in high-, middle-, or low-income countries.140
More recently, quality measures have been proposed for telestroke to ensure that the highest standards of care are maintained with the broader dissemination of this technology.141,142 These include infrastructure (eg, technical characteristics of the system, adherence to privacy regulations, adequate training and supervision, documentation practices), processes of care (eg, timeliness of care, rates of alteplase use), and performance criteria (eg, patient outcomes, patient satisfaction, safety events, technical failure rates). The recommendations stress that the use of widely accepted industry technology standards is encouraged and that the care provided during telestroke consultation should be similar to that given during on-site consultation.
Results from a recent clinical trial from the National Institutes of Health StrokeNet consortium showed that telemedicine-enabled rehabilitation (telerehabilitation) increases access to high-quality poststroke rehabilitation. As telestroke programs have proliferated, costs have reduced and a variety of alternative models for delivery have emerged from for-profit vendors, academic medical center networks, private practitioners, and others.137 Telestroke services have evolved from their initial focus on the acute thrombolysis encounter to incorporate postalteplase follow-up care, nonurgent consultation, and supporting care to remain local at lower-cost facilities when appropriate. In an exciting new development, 4G mobile broadband has enabled telestroke consultation into the prehospital arena, with MSUs in the United States deploying telemedicine and teleradiology to support acute care decision making and thrombolysis through remote consultation in specially equipped EMS vehicles.70,143 Others are reporting small-scale clinical trials of handheld interactive video in traditional ambulances to improve stroke recognition and triage.144,145
Given anticipated increases in computing power with the increasing speed and availability of wired and mobile broadband, it is likely that the next decade will be one of continued medical technology innovation. We are likely to see novel technologies interwoven into traditional workflows to create new avenues of care delivery and more seamless escalation and integration among phone, video, image, and data sharing. Telemedicine will be ubiquitous as passive and active monitoring of our daily health behaviors is integrated into smartphone apps with risk prediction models and decision-support algorithms that will trigger medical interventions. The power of these tools to promote healthy lifestyles and to increase adherence to secondary prevention of stroke and cardiovascular disease is untapped and may ultimately have a large impact on stroke systems of care.146
Patient-Reported Outcomes
Stroke is a global epidemic with a disproportionate burden among low-income countries.147 There is an urgent need to deliver more efficient and effective care that increases the value that health care provides to patients. Value in stroke care has been defined as the total benefit gained by a patient relative to the cost of obtaining that benefit (ie, stroke health outcomes divided by the cost to achieve those outcomes).148 Defining stroke-specific measurable outcomes that are meaningful to patients is critical to this equation and requires deep participation by patients to properly select the outcome measures. Initial efforts to create a utility-weighted version of the modified Rankin Scale score to better reflect the ordinal steps between each level have been published.149,150 The Stroke Impact Scale, Stroke-Specific Quality of Life Scale, health-related quality of life, and EuroQol 5-Dimensions Questionnaire are also validated measures focused on outcomes that are meaningful to patients.151–154
Alternatively, outcomes can be broken into the broad categories of survival, disease control, complications of treatment, and long-term quality of life.155 The importance of each can vary from patient to patient, between patient and caregiver, across diseases, and at different stages of disease and illness.156 Despite existing efforts in the area of patient-reported outcome measures to quantify stroke outcomes accurately with validated instruments, there is significant variability across instruments and domains, as well as no agreement about which critical measures should be routinely captured.157 It is also important to distinguish between metrics that are provider assessed versus patient self-reported. To define a set of global standards for measuring outcomes that matter most to stroke patients, an international expert panel was assembled representing patients, advocates, and clinician experts in stroke outcomes, registers, global health, epidemiology, and rehabilitation.158
The result was an international standard set of stroke patient-reported outcome measures that prioritized inclusion of risk adjustment variables, pragmatism over idealism, and completeness in data collection over breadth of areas surveyed and permitted retrospective abstraction and instruments that are perpetually freely available, permit recombination of elements, and are robust for comparison in both low- and high-income countries, with available cost utility values to calculate measures of cost-effectiveness.159 The Patient Reported Outcomes Measurement Information System 10-question short form is freely available in analog or digital format, is available in multiple languages, and can be converted to other scores of established instruments for comparison: the Short Form 36-Question Health Survey, the modified Rankin Scale, the Barthel Index, and the widely used EuroQol 5-Dimensions Questionnaire, which also allows calculation of quality-adjusted life-years.160,161
Transitions of Care
With stroke survivors potentially receiving care from multiple providers in different settings, transitions in care remain a major challenge. These transitions include the following: from prehospital to the admitting hospital, from the intensive care unit to the hospital floor, from the hospital to postacute settings (inpatient rehabilitation, skilled nursing facility, long-term acute care hospital, or home), and from a facility to home. Handoffs between providers occur at each transition point. Causes of ineffective transitions of care include breakdowns in communication, patient education, and accountability. Expectations may differ between senders and receivers of stroke survivors in transition. A lack of teamwork and respect may hinder the culture required to promote a successful handoff. An inadequate amount of time may be provided to complete the handoff. Stroke systems of care may lack standardized procedures and performance measures to address handoffs. Ineffective care transition processes may result in adverse events and higher hospital readmission rates and costs.162–164 Electronic health record “rounding lists” that are populated automatically (reducing human error) and can be shared by providers at each hospital-based transition should be more widely adopted. Emerging approaches to facilitating transitions of care and reducing readmission rates include the use of nurse navigators, as discussed in the Secondary Prevention/Postacute Care section, or social workers, which is being evaluated in a clinical trial funded by the Patient-Centered Outcomes Research Institute.165 For interfacility transitions, opportunities to break down the barriers in communication include the use of remote monitoring such as telemedicine.
Regulatory Issues in Stroke Systems of Care
In the United States, no federal legislation currently organizes or standardizes stroke care throughout the continuum. The Stroke Treatment and Ongoing Prevention Stroke Act of 2001,166 introduced in the US Senate in late 2001, called for increases in stroke prevention and treatment knowledge and awareness activities, the creation of a national stroke registry, and grants to train professionals and to create telestroke networks, but it did not pass in the 107th or 108th Congresses. In 2017, several pieces of legislation were introduced that seek to remove barriers for Medicare reimbursement of telestroke. The Furthering Access to Stroke Telemedicine Act of 2017,167 which was signed into law in early 2018, removes rural limits and expands Medicare coverage of telestroke services nationwide. The Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act168 also seeks to remove these barriers and is currently in the House after receiving a unanimous vote of approval in the Senate. For rehabilitation, CMS defines the scope of inpatient rehabilitation facilities, skilled nursing facilities, long-term acute care hospitals, home health agencies, and hospices. CMS coverage of services and payment, admission, and billing procedures is described in detail. However, CMS does not oversee or facilitate the organization of these facilities. Thus, postacute care of stroke survivors remains fragmented.
Some cities and states have taken responsibility to establish acute stroke systems of care. To date, 21 states have enacted statewide standards for the formal recognition of stroke facility designations and the development of transport protocols; 16 have passed legislation that requires stroke centers to participate in statewide stroke care data registries; and others have passed or may pass legislation that standardizes stroke practices such as prehospital and EMS treatment protocols.169 Cities such as Chicago have implemented prehospital stroke triage policies that have significantly improved prenotification and EMS use.170 However, standards and accrediting bodies may differ among states, thereby causing variations in the rates of use of alteplase and door-to-needle times. Thus, acute stroke quality of care and outcomes may vary greatly.73 For stroke rehabilitation, no state has legislated or set policy for standards of stroke rehabilitation triage and care. Thus, case managers report that rehabilitation bed availability, facility location, and “the speed with which you are able to discharge a stroke patient [to a facility]” affect where stroke survivors ultimately are discharged.124
Healthcare disparities also remain a significant issue in navigating stroke systems of care. For acute stroke, uninsured patients have longer lengths of stay compared with insured patients, largely because of the inability to transfer uninsured patients to inpatient rehabilitation settings.127 In Get With The Guidelines–Stroke, patients with ICH demonstrated differences in mortality, functional status, discharge destination, and quality-of-care measures associated with insurance status.171 For rehabilitation, insurance is the single greatest barrier in referring stroke survivors to the most appropriate level of postacute care and a significant barrier in referring stroke survivors to the most appropriate specific facility. Racial and ethnic minority groups are less likely to receive postacute rehabilitation after stroke.125,126 Thus, reforms are required to provide better access and more standardized care to stroke survivors throughout the continuum, resulting in fewer disparities in quality of stroke care and functional outcomes. A concerning development in the United States is insurance companies denying payment for conditions deemed not an emergency on the basis of the ultimate diagnosis, not on the symptoms that prompted the visit to the emergency department.172,173 An increasing frequency of such denials may affect patients’ willingness to seek emergency care given the potential financial implications.
Recommendations
1.
Efforts should be made to advance the use of technology and patient-reported outcomes and to facilitate improved care transitions in stroke care. These interventions should be refined on the basis of continuous quality improvement measurement and methods. Such efforts not only will bolster overall stroke prevention, treatment, and recovery but also may reduce the persistent disparities observed in stroke care. Before implementation, new policies should be evaluated for potential adverse impacts on access to care and disparities in care. (New)
2.
Federal or other governmental institutions should enact policies that standardize the organization of stroke care throughout the continuum. Such policies should aim to lower barriers to seeking emergency care for stroke, to ensure that stroke patients receive care at appropriate hospitals in a timely manner, and to facilitate access to secondary prevention and rehabilitation and recovery resources after stroke. (New)
Summary of Recommendations for Stroke Systems of Care
1.
A stroke system should support local and regional educational initiatives to increase stroke awareness (including stroke warning signs, risk factors, primary and secondary prevention, and recovery), aimed at the general population with enriched targeting of populations at increased risk for stroke and poor outcomes after stroke.
2.
Innovative behavioral interventions addressing barriers to healthy behaviors, prevention adherence, and warning sign action with tools such as digital phenotype analysis, social network analysis, gamification, and machine learning offer opportunity for sustainable behavioral change, and research in these areas should be encouraged.
3.
Public health leaders, along with medical professionals and others, should design and implement public education programs focused on stroke systems and the need to seek emergency care (by calling 9-1-1) in a rapid manner. These programs should be repetitive and designed to reach diverse populations. Further research is needed to establish the most effective programs for diverse populations.
4.
EMS leaders, in coordination with local, regional, and state agencies and in consultation with medical authorities and local experts, should develop triage paradigms and protocols that ensure that all patients with a known or suspected stroke are rapidly identified and assessed with a validated and standardized instrument for stroke screening such as FAST (Face, Arm, Speech, Time), Los Angeles Prehospital Stroke Screen, or CPSS.
a. In prehospital patients who screen positive for suspected stroke, a standard prehospital stroke severity assessment tool (such as the Cincinnati Stroke Triage Assessment Tool, Rapid Arterial Occlusion Evaluation, Los Angeles Motor Scale, and Field Assessment Stroke Triage for Emergency Destination) should be used to facilitate triage. In the absence of new data, it is reasonable to adapt the Mission: Lifeline algorithm to the needs of the community. Further research is needed to establish the most effective prehospital stroke severity triage scale, which may be one of the published scales or a novel scale or device.
b. Standardized approaches to prehospital stroke assessment, triage, and management should be encouraged for 9-1-1 call centers and EMS dispatchers. Further research is needed to establish the most effective programs for stroke recognition by 9-1-1 call centers and EMS dispatchers.
5.
The CSC, PSC, TCS, and ASRH framework provides an appropriate platform for the data-driven development of hospital-based processes of care and outcome metrics. All certification systems should meet or exceed these standards. All levels of stroke centers should work within their region in an integrated fashion, providing and sharing best practice.
a. TSC is a new hospital designation. Evidence supporting timely identification and treatment of thrombectomy-eligible ischemic stroke patients at TSCs is warranted. TSC treatment processes, technical outcomes (reperfusion rates), complications, and patient clinical outcomes should be tracked and reported.
b. Both the clinical benefit of decompressive craniectomy and the management of hemorrhagic stroke merit systems consideration of neurosurgical and neurocritical care resources in developing comprehensive systems for high-acuity stroke patients.
6.
Stroke centers should adopt approaches to secondary prevention that address all major modifiable risk factors and that are consistent with the national guidelines for all patients with a history or a suspected history of stroke or TIA. The focus of postacute care should be on reducing mortality, maximizing recovery, and preventing recurrent stroke and cardiovascular events.
7.
A stroke system should establish support systems to ensure that all patients discharged from hospitals and other facilities to their homes have appropriate follow-up with specialized stroke services when needed and primary care arranged on discharge. These efforts should include education and training for the patient and his or her family members. Clear, comprehensive, and timely communication across the inpatient and outpatient poststroke continuum of care is essential to ensure appropriate medical and rehabilitation care.
8.
To standardize the postacute care after stroke discharge, stroke centers should comprehensively screen for postacute complications, provide individualized care plans for patients during the transition of care, provide referrals to community services, and reinforce secondary prevention and self-management of stroke risk factors and lifestyle changes to decrease the risk of recurrent stroke. Trained stroke nurses, nurse practitioners, social workers, community health workers, and others should play a pivotal role.
9.
A stroke system should ensure that all stroke survivors receive a standardized screening evaluation during the initial hospitalization to determine whether rehabilitation services are needed and the type, timing, location, and duration of such therapy. Long-term primary care and specialist (physiatrist or neurology) follow-up should be arranged to identify patients with residual impairments so that these patients receive appropriate continued rehabilitation.
10.
A stroke system should periodically assess its level of available rehabilitation services and community resources.
11.
Efforts should be made to advance the use of technology and patient-reported outcomes and to facilitate improved care transitions in stroke care. These interventions should be refined on the basis of continuous quality improvement measurement and methods. Such efforts not only will bolster overall stroke prevention, treatment, and recovery but also may reduce the persistent disparities observed in stroke care. Before implementation, new policies should be evaluated for potential adverse impact on access to care and disparities in care.
12.
Federal or other governmental institutions should enact policies that standardize the organization of stroke care throughout the continuum. Such policies should aim to lower barriers to seeking emergency care for stroke, to ensure that stroke patients receive care at appropriate hospitals in a timely manner, and to facilitate access to secondary prevention and rehabilitation and recovery resources after stroke.
Conclusions
Since the AHA/ASA policy statement on stroke systems of care a decade ago,1 major advances have occurred in the management of acute stroke, and the use of telemedicine technology has markedly reduced fragmentation of care, allowing stroke experts to be available to acute stroke patients wherever the patient is located. Programs geared at further improving the knowledge of the public, encouraging primordial and primary prevention, advancing and facilitating acute therapy, improving secondary prevention and recovery from stroke, and reducing disparities in stroke care should be actively developed in a coordinated and collaborative fashion by providers and policymakers at the local, state, and national levels. Such efforts will continue to mitigate the effects of stroke on society.
References
1.
Schwamm LH, Pancioli A, Acker JE, Goldstein LB, Zorowitz RD, Shephard TJ, Moyer P, Gorman M, Johnston SC, Duncan PW, Gorelick P, Frank J, Stranne SK, Smith R, Federspiel W, Horton KB, Magnis E, Adams RJ. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association’s Task Force on the Development of Stroke Systems. Stroke. 2005;36:690–703. doi: 10.1161/01.STR.0000158165.42884.4F
2.
Higashida R, Alberts MJ, Alexander DN, Crocco TJ, Demaerschalk BM, Derdeyn CP, Goldstein LB, Jauch EC, Mayer SA, Meltzer NM, Peterson ED, Rosenwasser RH, Saver JL, Schwamm L, Summers D, Wechsler L, Wood JP; on behalf of the American Heart Association Advocacy Coordinating Committee. Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke. 2013;44:2961–2984. doi: 10.1161/STR.0b013e3182a6d2b2
3.
Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups [published correction appears in Stroke. 2007;38:e38]. Stroke. 2007;38:1655–1711. doi: 10.1161/STROKEAHA.107.181486
4.
Schwamm LH, Audebert HJ, Amarenco P, Chumbler NR, Frankel MR, George MG, Gorelick PB, Horton KB, Kaste M, Lackland DT, Levine SR, Meyer BC, Meyers PM, Patterson V, Stranne SK, White CJ; on behalf of the American Heart Association Stroke Council; Council on Epidemiology and Prevention; Interdisciplinary Council on Peripheral Vascular Disease; and the Council on Cardiovascular Radiology and Intervention. Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke. 2009;40:2635–2660. doi: 10.1161/STROKEAHA.109.192361
5.
Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD; on behalf of the American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s Strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586–613. doi: 10.1161/CIRCULATIONAHA.109.192703
6.
Schwamm L, Fayad P, Acker JE, Duncan P, Fonarow GC, Girgus M, Goldstein LB, Gregory T, Kelly-Hayes M, Sacco RL, Saver JL, Segrest W, Solis P, Yancy CW. Translating evidence into practice: a decade of efforts by the American Heart Association/American Stroke Association to reduce death and disability due to stroke: a presidential advisory from the American Heart Association/American Stroke Association. Stroke. 2010;41:1051–1065. doi: 10.1161/STR.0b013e3181d2da7d
7.
Ormseth CH, Sheth KN, Saver JL, Fonarow GC, Schwamm LH. The American Heart Association’s Get With the Guidelines (GWTG)-Stroke development and impact on stroke care. Stroke Vasc Neurol. 2017;2:94–105. doi: 10.1136/svn-2017-000092
8.
Gorelick PB, Furie KL, Iadecola C, Smith EE, Waddy SP, Lloyd-Jones DM, Bae HJ, Bauman MA, Dichgans M, Duncan PW, Girgus M, Howard VJ, Lazar RM, Seshadri S, Testai FD, van Gaal S, Yaffe K, Wasiak H, Zerna C; on behalf of the American Heart Association/American Stroke Association. Defining optimal brain health in adults: a presidential advisory from the American Heart Association/American Stroke Association. Stroke. 2017;48:e284–e303. doi: 10.1161/STR.0000000000000148
9.
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JHY, Alger HM, Wong SS, Muntner P; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2017 update: a report from the American Heart Association [published corrections appear in Circulation. 2017;135:e646 and Circulation. 2015;131:e545]. Circulation. 2017;135:e146–e603. doi: 10.1161/CIR.0000000000000485
10.
Judd SE, Kleindorfer DO, McClure LA, Rhodes JD, Howard G, Cushman M, Howard VJ. Self-report of stroke, transient ischemic attack, or stroke symptoms and risk of future stroke in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Stroke. 2013;44:55–60. doi: 10.1161/STROKEAHA.112.675033
11.
Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, Graham A, Moy CS, Howard G. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25:135–143. doi: 10.1159/000086678
12.
Deleted in proof.
13.
Ovbiagele B, Goldstein LB, Higashida RT, Howard VJ, Johnston SC, Khavjou OA, Lackland DT, Lichtman JH, Mohl S, Sacco RL, Saver JL, Trogdon JG; on behalf of the American Heart Association Advocacy Coordinating Committee and Stroke Council. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association [published correction appears in Stroke. 2015;46:e179]. Stroke. 2013;44:2361–2375. doi: 10.1161/STR.0b013e31829734f2
14.
Chau PH, Tang MW, Yeung F, Chan TW, Cheng JO, Woo J. Can short-term residential care for stroke rehabilitation help to reduce the institutionalization of stroke survivors? Clin Interv Aging. 2014;9:283–291. doi: 10.2147/CIA.S56532
15.
Khavjou, OA, Phelps, D, Leib, A. Projections of cardiovascular disease prevalence and costs: 2015–2035. 2017. https://healthmetrics.heart.org/wp-content/uploads/2017/10/Projections-of-Cardiovascular-Disease.pdf. Accessed July 28, 2018.
16.
Ganesh A, Lindsay P, Fang J, Kapral MK, Côté R, Joiner I, Hakim AM, Hill MD. Integrated systems of stroke care and reduction in 30-day mortality: a retrospective analysis. Neurology. 2016;86:898–904. doi: 10.1212/WNL.0000000000002443
17.
Song S, Fonarow GC, Olson DM, Liang L, Schulte PJ, Hernandez AF, Peterson ED, Reeves MJ, Smith EE, Schwamm LH, Saver JL. Association of Get With The Guidelines–Stroke program participation and clinical outcomes for Medicare beneficiaries with ischemic stroke. Stroke. 2016;47:1294–1302. doi: 10.1161/STROKEAHA.115.011874
18.
Branas CC, MacKenzie EJ, Williams JC, Schwab CW, Teter HM, Flanigan MC, Blatt AJ, ReVelle CS. Access to trauma centers in the United States. JAMA. 2005;293:2626–2633. doi: 10.1001/jama.293.21.2626
19.
Agency for Healthcare Research and Quality. Effective Health Care Program Stakeholder Guide. 2014. http://www.ahrq.gov/research/findings/evidence-based-reports/stakeholderguide/index.html. Accessed September 20, 2014.
20.
Gesell SB, Klein KP, Halladay J, Bettger JP, Freburger J, Cummings DM, Lutz BJ, Coleman S, Bushnell C, Rosamond W, Duncan PW. Methods guiding stakeholder engagement in planning a pragmatic study on changing stroke systems of care. J Clin Transl Sci. 2017;1:121–128. doi: 10.1017/cts.2016.26
21.
Deedwania, PC. Prevention of Cardiovascular Disease: A Continuum: An Issue of Cardiology Clinics. Vol 29. London, UK: Elsevier Health Sciences; 2011.
22.
Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. Deaths: final data for 2014. Natl Vital Stat Rep. 2016;65:1–122.
23.
Centers for Disease Control and Prevention. Prevalence and most common causes of disability among adults–United States, 2005. MMWR Morb Mortal Wkly Rep. 2009;58:421–426.
24.
Weintraub WS, Daniels SR, Burke LE, Franklin BA, Goff DC, Hayman LL, Lloyd-Jones D, Pandey DK, Sanchez EJ, Schram AP, Whitsel LP; on behalf of the American Heart Association Advocacy Coordinating Committee; Council on Cardiovascular Disease in the Young; Council on the Kidney in Cardiovascular Disease; Council on Epidemiology and Prevention; Council on Cardiovascular Nursing; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Clinical Cardiology, and Stroke Council. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation. 2011;124:967–990. doi: 10.1161/CIR.0b013e3182285a81
25.
Bartolucci AA, Tendera M, Howard G. Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. Am J Cardiol. 2011;107:1796–1801. doi: 10.1016/j.amjcard.2011.02.325
26.
Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007;370:2044–2053. doi: 10.1016/S0140-6736(07)61698-5
27.
Maciosek MV, LaFrance AB, Dehmer SP, McGree DA, Xu Z, Flottemesch TJ, Solberg LI. Health benefits and cost-effectiveness of brief clinician tobacco counseling for youth and adults. Ann Fam Med. 2017;15:37–47. doi: 10.1370/afm.2022
28.
Centers for Disease Control and Prevention. Healthy People 2010 final review. 2010. https://www.cdc.gov/nchs/healthy_people/hp2010/hp2010_final_review.htm. Accessed June 13, 2017.
29.
US Department of Health and Human Services Office of Disease Prevention and Health Promotion. Healthy People 2020. 2017. https://www.healthypeople.gov/. Accessed June 13, 2017.
30.
US Department of Health and Human Services. Million Hearts. 2017. https://millionhearts.hhs.gov/. Accessed June 13, 2017.
31.
Havranek EP, Mujahid MS, Barr DA, Blair IV, Cohen MS, Cruz-Flores S, Davey-Smith G, Dennison-Himmelfarb CR, Lauer MS, Lockwood DW, Rosal M, Yancy CW; on behalf of the American Heart Association Council on Quality of Care and Outcomes Research, Council on Epidemiology and Prevention, Council on Cardiovascular and Stroke Nursing, Council on Lifestyle and Cardiometabolic Health, and Stroke Council. Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2015;132:873–898. doi: 10.1161/CIR.0000000000000228
32.
Frieden TR. A framework for public health action: the health impact pyramid. Am J Public Health. 2010;100:590–595. doi: 10.2105/AJPH.2009.185652
33.
American Heart Association/American Stroke Association. Target: stroke. 2017. http://www.strokeassociation.org/STROKEORG/Professionals/TargetStroke/Target-Stroke_UCM_314495_SubHomePage.jsp. Accessed June 13, 2017.
34.
American Heart Association/American Stroke Association. Together to end stroke. 2017. http://www.strokeassociation.org/STROKEORG/General/Together-to-End-Stroke_UCM_448718_SubHomePage.jsp. Accessed June 13, 2017.
35.
American Heart Association/American Stroke Association. Life’s Simple 7. 2017. http://www.heart.org/HEARTORG/Conditions/My-Life-Check—Lifes-Simple-7_UCM_471453_Article.jsp#.WUA01-srLIU. Accessed June 13, 2017.
36.
Waddy SP, Cotsonis G, Lynn MJ, Frankel MR, Chaturvedi S, Williams JE, Chimowitz M. Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke. 2009;40:719–725. doi: 10.1161/STROKEAHA.108.526624
37.
Cruz-Flores S, Rabinstein A, Biller J, Elkind MS, Griffith P, Gorelick PB, Howard G, Leira EC, Morgenstern LB, Ovbiagele B, Peterson E, Rosamond W, Trimble B, Valderrama AL; on behalf of the American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council on Quality of Care and Outcomes Research. Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2091–2116. doi: 10.1161/STR.0b013e3182213e24
38.
Wall HK, Beagan BM, O’Neill J, Foell KM, Boddie-Willis CL. Addressing stroke signs and symptoms through public education: the Stroke Heroes Act FAST campaign. Prev Chronic Dis. 2008;5:A49.
39.
American Heart Association/American Stroke Association. Power to end stroke. 2006. http://www.empoweredtoserve.org/index.php/power-to-end-stroke/. Accessed June 13, 2017.
40.
Salinas J, Schwamm LH. Behavioral interventions for stroke prevention: the need for a new conceptual model. Stroke. 2017;48:1706–1714. doi: 10.1161/STROKEAHA.117.015909
41.
Stroke’s No Joke [video]. 2009. https://www.youtube.com/watch?v=C4dygYaNyhY. Accessed July 28, 2018.
42.
Ojike N, Ravenell J, Seixas A, Masters-Israilov A, Rogers A, Jean-Louis G, Ogedegbe G, McFarlane SI. Racial disparity in stroke awareness in the US: an analysis of the 2014 National Health Interview Survey. J Neurol Neurophysiol. 2016;7:365.
43.
Teuschl Y, Brainin M. Stroke education: discrepancies among factors influencing prehospital delay and stroke knowledge. Int J Stroke. 2010;5:187–208. doi: 10.1111/j.1747-4949.2010.00428.x
44.
Skolarus LE, Zimmerman MA, Bailey S, Dome M, Murphy JB, Kobrossi C, Dombrowski SU, Burke JF, Morgenstern LB. Stroke ready intervention: community engagement to decrease prehospital delay. J Am Heart Assoc. 2016;5:e003331. doi: 10.1161/JAHA.116.003331
45.
Boden-Albala B, Edwards DF, St Clair S, Wing JJ, Fernandez S, Gibbons MC, Hsia AW, Morgenstern LB, Kidwell CS. Methodology for a community-based stroke preparedness intervention: the Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities Study. Stroke. 2014;45:2047–2052. doi: 10.1161/STROKEAHA.113.003502
46.
Morgenstern LB, Staub L, Chan W, Wein TH, Bartholomew LK, King M, Felberg RA, Burgin WS, Groff J, Hickenbottom SL, Saldin K, Demchuk AM, Kalra A, Dhingra A, Grotta JC. Improving delivery of acute stroke therapy: the TLL Temple Foundation Stroke Project. Stroke. 2002;33:160–166.
47.
O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, Lopez-Jaramillo P, Damasceno A, Langhorne P, McQueen MJ, Rosengren A, Dehghan M, Hankey GJ, Dans AL, Elsayed A, Avezum A, Mondo C, Diener HC, Ryglewicz D, Czlonkowska A, Pogosova N, Weimar C, Iqbal R, Diaz R, Yusoff K, Yusufali A, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Oveisgharan S, Al Hussain F, Magazi D, Nilanont Y, Ferguson J, Pare G, Yusuf S; INTERSTROKE Investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388:761–775. doi: 10.1016/S0140-6736(16)30506-2
48.
Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31:143–164. doi: 10.1177/1090198104263660
49.
Adeoye O, Lindsell C, Broderick J, Alwell K, Jauch E, Moomaw CJ, Flaherty ML, Pancioli A, Kissela B, Kleindorfer D. Emergency medical services use by stroke patients: a population-based study. Am J Emerg Med. 2009;27:141–145. doi: 10.1016/j.ajem.2008.02.004
50.
Lin CB, Peterson ED, Smith EE, Saver JL, Liang L, Xian Y, Olson DM, Shah BR, Hernandez AF, Schwamm LH, Fonarow GC. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes. 2012;5:514–522. doi: 10.1161/CIRCOUTCOMES.112.965210
51.
Ekundayo OJ, Saver JL, Fonarow GC, Schwamm LH, Xian Y, Zhao X, Hernandez AF, Peterson ED, Cheng EM. Patterns of emergency medical services use and its association with timely stroke treatment: findings from Get With the Guidelines–Stroke. Circ Cardiovasc Qual Outcomes. 2013;6:262–269. doi: 10.1161/CIRCOUTCOMES.113.000089
52.
Mochari-Greenberger H, Xian Y, Hellkamp AS, Schulte PJ, Bhatt DL, Fonarow GC, Saver JL, Reeves MJ, Schwamm LH, Smith EE. Racial/ethnic and sex differences in emergency medical services transport among hospitalized US stroke patients: analysis of the national Get With The Guidelines–Stroke Registry. J Am Heart Assoc. 2015;4:e002099. doi: 10.1161/JAHA.115.002099
53.
De Luca A, Giorgi Rossi P, Villa GF; Stroke Group Italian Society Pre Hospital Emergency Services. The use of Cincinnati Prehospital Stroke Scale during telephone dispatch interview increases the accuracy in identifying stroke and transient ischemic attack symptoms. BMC Health Serv Res. 2013;13:513. doi: 10.1186/1472-6963-13-513
54.
Brandler ES, Sharma M, Sinert RH, Levine SR. Prehospital stroke scales in urban environments: a systematic review. Neurology. 2014;82:2241–2249. doi: 10.1212/WNL.0000000000000523
55.
Schwartz J, Dreyer RP, Murugiah K, Ranasinghe I. Contemporary prehospital emergency medical services response times for suspected stroke in the United States. Prehosp Emerg Care. 2016;20:560–565. doi: 10.3109/10903127.2016.1139219
56.
Saver JL, Goyal M, van der Lugt A, Menon BK, Majoie CB, Dippel DW, Campbell BC, Nogueira RG, Demchuk AM, Tomasello A, Cardona P, Devlin TG, Frei DF, du Mesnil de Rochemont R, Berkhemer OA, Jovin TG, Siddiqui AH, van Zwam WH, Davis SM, Castaño C, Sapkota BL, Fransen PS, Molina C, van Oostenbrugge RJ, Chamorro Á, Lingsma H, Silver FL, Donnan GA, Shuaib A, Brown S, Stouch B, Mitchell PJ, Davalos A, Roos YB, Hill MD; HERMES Collaborators. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA. 2016;316:1279–1288. doi: 10.1001/jama.2016.13647
57.
Saver JL, Goyal M, Hill MD; HERMES Collaborators. Time to endovascular thrombectomy for acute stroke-reply. JAMA. 2017;317:1175–1176. doi: 10.1001/jama.2017.0373
58.
Katz BS, McMullan JT, Sucharew H, Adeoye O, Broderick JP. Design and validation of a prehospital scale to predict stroke severity: Cincinnati Prehospital Stroke Severity Scale. Stroke. 2015;46:1508–1512. doi: 10.1161/STROKEAHA.115.008804
59.
Lima FO, Silva GS, Furie KL, Frankel MR, Lev MH, Camargo ÉC, Haussen DC, Singhal AB, Koroshetz WJ, Smith WS, Nogueira RG. Field assessment stroke triage for emergency destination: a simple and accurate prehospital scale to detect large vessel occlusion strokes. Stroke. 2016;47:1997–2002. doi: 10.1161/STROKEAHA.116.013301
60.
Perez de la Ossa N, Carrera D, Gorchs M, Querol M, Millán M, Gomis M, Dorado L, López-Cancio E, Hernández-Pérez M, Chicharro V, Escalada X, Jiménez X, Dávalos A. Design and validation of a prehospital stroke scale to predict large arterial occlusion: the rapid arterial occlusion evaluation scale. Stroke. 2014;45:87–91. doi: 10.1161/STROKEAHA.113.003071
61.
Hastrup S, Damgaard D, Johnsen SP, Andersen G. Prehospital acute stroke severity scale to predict large artery occlusion: design and comparison with other scales. Stroke. 2016;47:1772–1776. doi: 10.1161/STROKEAHA.115.012482
62.
Singer OC, Dvorak F, du Mesnil de Rochemont R, Lanfermann H, Sitzer M, Neumann-Haefelin T. A simple 3-item stroke scale: comparison with the National Institutes of Health Stroke Scale and prediction of middle cerebral artery occlusion. Stroke. 2005;36:773–776. doi: 10.1161/01.STR.0000157591.61322.df
63.
Nazliel B, Starkman S, Liebeskind DS, Ovbiagele B, Kim D, Sanossian N, Ali L, Buck B, Villablanca P, Vinuela F, Duckwiler G, Jahan R, Saver JL. A brief prehospital stroke severity scale identifies ischemic stroke patients harboring persisting large arterial occlusions. Stroke. 2008;39:2264–2267. doi: 10.1161/STROKEAHA.107.508127
64.
McMullan JT, Katz B, Broderick J, Schmit P, Sucharew H, Adeoye O. Prospective prehospital evaluation of the Cincinnati Stroke Triage Assessment Tool. Prehosp Emerg Care. 2017;21:481–488.
65.
Carrera D, Campbell BC, Cortés J, Gorchs M, Querol M, Jiménez X, Millán M, Dávalos A, Pérez de la Ossa N. Predictive value of modifications of the prehospital Rapid Arterial Occlusion Evaluation Scale for large vessel occlusion in patients with acute stroke. J Stroke Cerebrovasc Dis. 2017;26:74–77. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.032
66.
Kim JT, Chung PW, Starkman S, Sanossian N, Stratton SJ, Eckstein M, Pratt FD, Conwit R, Liebeskind DS, Sharma L, Restrepo L, Tenser MK, Valdes-Sueiras M, Gornbein J, Hamilton S, Saver JL; FAST-MAG Trial (Field Administration of Stroke Therapy–Magnesium) Nurse-Coordinators and Investigators. Field validation of the Los Angeles Motor Scale as a tool for paramedic assessment of stroke severity. Stroke. 2017;48:298–306. doi: 10.1161/STROKEAHA.116.015247
67.
American Heart Association. Severity-based stroke triage algorithm for EMS. http://www.heart.org/missionlifelinestroke. Accessed July 28, 2018.
68.
Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, Pan W, Olson DM, Hernandez AF, Peterson ED, Schwamm LH. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013;309:2480–2488. doi: 10.1001/jama.2013.6959
69.
Ebinger M, Winter B, Wendt M, Weber JE, Waldschmidt C, Rozanski M, Kunz A, Koch P, Kellner PA, Gierhake D, Villringer K, Fiebach JB, Grittner U, Hartmann A, Mackert BM, Endres M, Audebert HJ; STEMO Consortium. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA. 2014;311:1622–1631. doi: 10.1001/jama.2014.2850
70.
Wu TC, Parker SA, Jagolino A, Yamal JM, Bowry R, Thomas A, Yu A, Grotta JC. Telemedicine can replace the neurologist on a mobile stroke unit. Stroke. 2017;48:493–496. doi: 10.1161/STROKEAHA.116.015363
71.
Ebinger M, Kunz A, Wendt M, Rozanski M, Winter B, Waldschmidt C, Weber J, Villringer K, Fiebach JB, Audebert HJ. Effects of golden hour thrombolysis: a Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy. JAMA Neurol. 2015;72:25–30. doi: 10.1001/jamaneurol.2014.3188
72.
Fassbender K, Grotta JC, Walter S, Grunwald IQ, Ragoschke-Schumm A, Saver JL. Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges. Lancet Neurol. 2017;16:227–237. doi: 10.1016/S1474-4422(17)30008-X
73.
Man S, Cox M, Patel P, Smith EE, Reeves MJ, Saver JL, Bhatt DL, Xian Y, Schwamm LH, Fonarow GC. Differences in acute ischemic stroke quality of care and outcomes by primary stroke center certification organization. Stroke. 2017;48:412–419. doi: 10.1161/STROKEAHA.116.014426
74.
Leifer D, Bravata DM, Connors JJ, Hinchey JA, Jauch EC, Johnston SC, Latchaw R, Likosky W, Ogilvy C, Qureshi AI, Summers D, Sung GY, Williams LS, Zorowitz R; on behalf of the American Heart Association Special Writing Group of the Stroke Council; Atherosclerotic Peripheral Vascular Disease Working Group; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association [published correction appears in Stroke. 2011;42:e369]. Stroke. 2011;42:849–877. doi: 10.1161/STR.0b013e318208eb99
75.
The Joint Commission. Input sought on proposed certification for thrombectomy-capable stroke centers. 2017. https://www.jointcommission.org/issues/article.aspx?Article=%2FRubzLTEhCFRKMmGA1ngtRNMmMHn7kVuT6GjtY%2BpxHw%3D&print=y. Accessed August 1, 2017.
76.
Gupta R, Horev A, Nguyen T, Gandhi D, Wisco D, Glenn BA, Tayal AH, Ludwig B, Terry JB, Gershon RY, Jovin T, Clemmons PF, Frankel MR, Cronin CA, Anderson AM, Hussain MS, Sheth KN, Belagaje SR, Tian M, Nogueira RG. Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomes. J Neurointerv Surg. 2013;5:294–297. doi: 10.1136/neurintsurg-2011-010245
77.
Fransen PS, Beumer D, Berkhemer OA, van den Berg LA, Lingsma H, van der Lugt A, van Zwam WH, van Oostenbrugge RJ, Roos YB, Majoie CB, Dippel DW; MR CLEAN Investigators. MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials. 2014;15:343. doi: 10.1186/1745-6215-15-343
78.
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, Bang OY, Baxter BW, Burns PA, Choe H, Heo JH, Holmstedt CA, Jankowitz B, Kelly M, Linares G, Mandzia JL, Shankar J, Sohn SI, Swartz RH, Barber PA, Coutts SB, Smith EE, Morrish WF, Weill A, Subramaniam S, Mitha AP, Wong JH, Lowerison MW, Sajobi TT, Hill MD; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–1030. doi: 10.1056/NEJMoa1414905
79.
Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Baxter BW, Devlin TG, Lopes DK, Reddy VK, du Mesnil de Rochemont R, Singer OC, Jahan R; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285–2295. doi: 10.1056/NEJMoa1415061
80.
Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ, Parsons MW, Oxley TJ, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Priglinger M, Ang T, Scroop R, Barber PA, McGuinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Badve M, Rice H, de Villiers L, Ma H, Desmond PM, Donnan GA, Davis SM; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–1018. doi: 10.1056/NEJMoa1414792
81.
Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, Johnston KC, Johnston SC, Khalessi AA, Kidwell CS, Meschia JF, Ovbiagele B, Yavagal DR; on behalf of the American Heart Association Stroke Council. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:3020–3035. doi: 10.1161/STR.0000000000000074
82.
Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, Sila CA, Hassan AE, Millan M, Levy EI, Mitchell P, Chen M, English JD, Shah QA, Silver FL, Pereira VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellinger FR, Feng L, Kirmani JF, Lopes DK, Jankowitz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Malik AM, Furlan AJ, Rubiera M, Aghaebrahim A, Olivot JM, Tekle WG, Shields R, Graves T, Lewis RJ, Smith WS, Liebeskind DS, Saver JL, Jovin TG; DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11–21.
83.
Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG, et al., for the DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708–718.
84.
Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, Hacke W. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke. 1998;29:1888–1893.
85.
Gupta R, Connolly ES, Mayer S, Elkind MS. Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke. 2004;35:539–543. doi: 10.1161/01.STR.0000109772.64650.18
86.
Jüttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J, Witte S, Jenetzky E, Hacke W; DESTINY Study Group. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38:2518–2525. doi: 10.1161/STROKEAHA.107.485649
87.
Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard JP, Boutron C, Couvreur G, Rouanet F, Touzé E, Guillon B, Carpentier A, Yelnik A, George B, Payen D, Bousser MG; DECIMAL Investigators. Sequential-design, multicenter, randomized, controlled trial of early Decompressive Craniectomy in Malignant Middle Cerebral Artery Infarction (DECIMAL Trial). Stroke. 2007;38:2506–2517. doi: 10.1161/STROKEAHA.107.485235
88.
Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P; on behalf of the American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–1737. doi: 10.1161/STR.0b013e3182587839
89.
Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29:635–640.
90.
McTaggart RA, Ansari SA, Goyal M, Abruzzo TA, Albani B, Arthur AJ, Alexander MJ, Albuquerque FC, Baxter B, Bulsara KR, Chen M, Almandoz JE, Fraser JF, Frei D, Gandhi CD, Heck DV, Hetts SW, Hussain MS, Kelly M, Klucznik R, Lee SK, Leslie-Mawzi T, Meyers PM, Prestigiacomo CJ, Pride GL, Patsalides A, Starke RM, Sunenshine P, Rasmussen PA, Jayaraman MV; Standards and Guidelines Committee of the Society of NeuroInterventional Surgery (SNIS). Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the Standards and Guidelines Committee of the Society of NeuroInterventional Surgery. J Neurointerv Surg. 2017;9:316–323. doi: 10.1136/neurintsurg-2015-011984
91.
Deleted in proof.
92.
McTaggart RA, Yaghi S, Cutting SM, Hemendinger M, Baird GL, Haas RA, Furie KL, Jayaraman MV. Association of a primary stroke center protocol for suspected stroke by large-vessel occlusion with efficiency of care and patient outcomes. JAMA Neurol. 2017;74:793–800. doi: 10.1001/jamaneurol.2017.0477
93.
Fonarow GC, Alberts MJ, Broderick JP, Jauch EC, Kleindorfer DO, Saver JL, Solis P, Suter R, Schwamm LH. Stroke outcomes measures must be appropriately risk adjusted to ensure quality care of patients: a presidential advisory from the American Heart Association/American Stroke Association [published correction appears in Stroke. 2014;45:e96]. Stroke. 2014;45:1589–1601. doi: 10.1161/STR.0000000000000014
94.
Katzan IL, Spertus J, Bettger JP, Bravata DM, Reeves MJ, Smith EE, Bushnell C, Higashida RT, Hinchey JA, Holloway RG, Howard G, King RB, Krumholz HM, Lutz BJ, Yeh RW; on behalf of the American Heart Association Stroke Council; Council on Quality of Care and Outcomes Research; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:918–944. doi: 10.1161/01.str.0000441948.35804.77
95.
Zaidat OO, Lazzaro M, McGinley E, Edgell RC, Nguyen T, Linfante I, Janjua N. Demand-supply of neurointerventionalists for endovascular ischemic stroke therapy. Neurology. 2012;79(suppl 1):S35–S41. doi: 10.1212/WNL.0b013e31826957ef
96.
Adeoye O, Albright KC, Carr BG, Wolff C, Mullen MT, Abruzzo T, Ringer A, Khatri P, Branas C, Kleindorfer D. Geographic access to acute stroke care in the United States. Stroke. 2014;45:3019–3024. doi: 10.1161/STROKEAHA.114.006293
97.
Mullen MT, Branas CC, Kasner SE, Wolff C, Williams JC, Albright KC, Carr BG. Optimization modeling to maximize population access to comprehensive stroke centers. Neurology. 2015;84:1196–1205. doi: 10.1212/WNL.0000000000001390
98.
Day AL, Siddiqui AH, Meyers PM, Jovin TG, Derdeyn CP, Hoh BL, Riina H, Linfante I, Zaidat O, Turk A, Howington JU, Mocco J, Ringer AJ, Veznedaroglu E, Khalessi AA, Levy EI, Woo H, Harbaugh R, Giannotta S. Training standards in neuroendovascular surgery: program accreditation and practitioner certification. Stroke. 2017;48:2318–2325. doi: 10.1161/STROKEAHA.117.016560
99.
Accreditation Council for Graduate Medical Education. ACGME program requirements for graduate medical education in endovascular surgical neuroradiology: ACGME approved focused revision: September 30, 2012. https://www.acgme.org/Portals/0/PFAssets/ProgramRequirements/424_pediatric_diag_rad_2016_1-YR.pdf. Accessed July 28, 2018.
100.
Hong KS, Yegiaian S, Lee M, Lee J, Saver JL. Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design. Circulation. 2011;123:2111–2119. doi: 10.1161/CIRCULATIONAHA.109.934786
101.
Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, Ellrodt G, Cannon CP, Liang L, Peterson E, Labresh KA. Get With the Guidelines–Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation. 2009;119:107–115. doi: 10.1161/CIRCULATIONAHA.108.783688
102.
Medicare Quality Initiatives Patient Assessment Instruments. https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/MMS/Downloads/Hospital-Wide_All-Condition_All-Procedure_Risk-Standardized-Mortality-Measure_Public-Comment.pdf. Accessed July 28, 2018.
103.
Mittal MK, Rabinstein AA, Mandrekar J, Brown RD, Flemming KD. A population-based study for 30-d hospital readmissions after acute ischemic stroke. Int J Neurosci. 2017;127:305–313. doi: 10.1080/00207454.2016.1207642
104.
Le ST, Josephson SA, Puttgen HA, Gibson L, Guterman EL, Leicester HM, Graf CL, Probasco JC. Many neurology readmissions are nonpreventable. Neurohospitalist. 2017;7:61–69. doi: 10.1177/1941874416674409
105.
Chin DL, Bang H, Manickam RN, Romano PS. Rethinking thirty-day hospital readmissions: shorter intervals might be better indicators of quality of care. Health Aff (Millwood). 2016;35:1867–1875. doi: 10.1377/hlthaff.2016.0205
106.
Lindsay P, Furie KL, Davis SM, Donnan GA, Norrving B. World Stroke Organization global stroke services guidelines and action plan. Int J Stroke. 2014;9(suppl A100):4–13. doi: 10.1111/ijs.12371
107.
Kane RL, Lin WC, Blewett LA. Geographic variation in the use of post-acute care. Health Serv Res. 2002;37:667–682.
108.
Prvu Bettger J, McCoy L, Smith EE, Fonarow GC, Schwamm LH, Peterson ED. Contemporary trends and predictors of postacute service use and routine discharge home after stroke. J Am Heart Assoc. 2015;4:e001038. doi: 10.1161/JAHA.114.001038
109.
Brown TM, Parmar G, Durant RW, Halanych JH, Hovater M, Muntner P, Prineas RJ, Roth DL, Samdarshi TE, Safford MM. Health professional shortage areas, insurance status, and cardiovascular disease prevention in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. J Health Care Poor Underserved. 2011;22:1179–1189. doi: 10.1353/hpu.2011.0127
110.
Cameron JI, Gignac MA. “Timing It Right”: a conceptual framework for addressing the support needs of family caregivers to stroke survivors from the hospital to the home. Patient Educ Couns. 2008;70:305–314. doi: 10.1016/j.pec.2007.10.020
111.
Hodson T, Gustafsson L, Cornwell P, Love A. Post-acute hospital healthcare services for people with mild stroke: a scoping review. Top Stroke Rehabil. 2017;24:288–298. doi: 10.1080/10749357.2016.1267831
112.
Condon C, Lycan S, Duncan P, Bushnell C. Reducing readmissions after stroke with a structured nurse practitioner/registered nurse transitional stroke program. Stroke. 2016;47:1599–1604. doi: 10.1161/STROKEAHA.115.012524
113.
Fearon P, Langhorne P, Early Supported Discharge Trialists. Services for reducing duration of hospital care for acute stroke patients. Cochrane Database Syst Rev. 2012:CD000443.
114.
Fisher RJ, Gaynor C, Kerr M, Langhorne P, Anderson C, Bautz-Holter E, Indredavik B, Mayo NE, Power M, Rodgers H, Rønning OM, Widén Holmqvist L, Wolfe CD, Walker MF. A consensus on stroke: early supported discharge. Stroke. 2011;42:1392–1397. doi: 10.1161/STROKEAHA.110.606285
115.
Duncan PW, Bushnell CD, Rosamond WD, Jones Berkeley SB, Gesell SB, D’Agostino RB, Ambrosius WT, Barton-Percival B, Bettger JP, Coleman SW, Cummings DM, Freburger JK, Halladay J, Johnson AM, Kucharska-Newton AM, Lundy-Lamm G, Lutz BJ, Mettam LH, Pastva AM, Sissine ME, Vetter B. The Comprehensive Post-Acute Stroke Services (COMPASS) study: design and methods for a cluster-randomized pragmatic trial. BMC Neurol. 2017;17:133. doi: 10.1186/s12883-017-0907-1
116.
Jack HE, Arabadjis SD, Sun L, Sullivan EE, Phillips RS. Impact of community health workers on use of healthcare services in the United States: a systematic review. J Gen Intern Med. 2017;32:325–344. doi: 10.1007/s11606-016-3922-9
117.
Towfighi A, Cheng EM, Ayala-Rivera M, McCreath H, Sanossian N, Dutta T, Mehta B, Bryg R, Rao N, Song S, Razmara A, Ramirez M, Sivers-Teixeira T, Tran J, Mojarro-Huang E, Montoya A, Corrales M, Martinez B, Willis P, Macias M, Ibrahim N, Wu S, Wacksman J, Haber H, Richards A, Barry F, Hill V, Mittman B, Cunningham W, Liu H, Ganz DA, Factor D, Vickrey BG. Randomized controlled trial of a coordinated care intervention to improve risk factor control after stroke or transient ischemic attack in the safety net: Secondary stroke prevention by Uniting Community and Chronic care model teams Early to End Disparities (SUCCEED). BMC Neurol. 2017;17:24. doi: 10.1186/s12883-017-0792-7
118.
Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, Deruyter F, Eng JJ, Fisher B, Harvey RL, Lang CE, MacKay-Lyons M, Ottenbacher KJ, Pugh S, Reeves MJ, Richards LG, Stiers W, Zorowitz RD; on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association [published corrections appear in Stroke. 2017;48:e78 and Stroke. 2017;48:e369]. Stroke. 2016;47:e98–e169. doi: 10.1161/STR.0000000000000098
119.
Miller EL, Murray L, Richards L, Zorowitz RD, Bakas T, Clark P, Billinger SA; on behalf of the American Heart Association Council on Cardiovascular Nursing and the Stroke Council. Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the American Heart Association. Stroke. 2010;41:2402–2448. doi: 10.1161/STR.0b013e3181e7512b
120.
Buntin MB, Garten AD, Paddock S, Saliba D, Totten M, Escarce JJ. How much is postacute care use affected by its availability? Health Serv Res. 2005;40:413–434. doi: 10.1111/j.1475-6773.2005.00365.x
121.
Liu K, Wissoker D, Rimes C. Determinants and costs of Medicare post-acute care provided by SNFs and HHAs. Inquiry. 1998;35:49–61.
122.
Deleted in proof.
123.
Deleted in proof.
124.
Sicklick A, Stein J, Hedeman R, Prvu-Bettger J, Magdon-Ismail Z, Martin L. Selection of postacute rehabilitation facilities in the Northeast: a survey of discharge planners [abstract]. Stroke. 2014;45:A151.
125.
Freburger JK, Holmes GM, Ku LJ, Cutchin MP, Heatwole-Shank K, Edwards LJ. Disparities in postacute rehabilitation care for stroke: an analysis of the state inpatient databases. Arch Phys Med Rehabil. 2011;92:1220–1229. doi: 10.1016/j.apmr.2011.03.019
126.
Ottenbacher KJ, Campbell J, Kuo YF, Deutsch A, Ostir GV, Granger CV. Racial and ethnic differences in postacute rehabilitation outcomes after stroke in the United States. Stroke. 2008;39:1514–1519. doi: 10.1161/STROKEAHA.107.501254
127.
Gezmu T, Gizzi MS, Kirmani JF, Schneider D, Moussavi M. Disparities in acute stroke severity, outcomes, and care relative to health insurance status. J Stroke Cerebrovasc Dis. 2014;23:e93–e98. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.027
128.
Hand B, Page SJ, White S. Stroke survivors scoring zero on the NIH Stroke Scale score still exhibit significant motor impairment and functional limitation. Stroke Res Treat. 2014;2014:462681. doi: 10.1155/2014/462681
129.
Martin-Schild S, Albright KC, Tanksley J, Pandav V, Jones EB, Grotta JC, Savitz SI. Zero on the NIHSS does not equal the absence of stroke. Ann Emerg Med. 2011;57:42–45. doi: 10.1016/j.annemergmed.2010.06.564
130.
Pandyan AD, Cameron M, Powell J, Stott DJ, Granat MH. Contractures in the post-stroke wrist: a pilot study of its time course of development and its association with upper limb recovery. Clin Rehabil. 2003;17:88–95. doi: 10.1191/0269215503cr587oa
131.
Palmer R, Enderby P, Cooper C, Latimer N, Julious S, Paterson G, Dimairo M, Dixon S, Mortley J, Hilton R, Delaney A, Hughes H. Computer therapy compared with usual care for people with long-standing aphasia poststroke: a pilot randomized controlled trial. Stroke. 2012;43:1904–1911. doi: 10.1161/STROKEAHA.112.650671
132.
Prabhakaran S, Zarahn E, Riley C, Speizer A, Chong JY, Lazar RM, Marshall RS, Krakauer JW. Inter-individual variability in the capacity for motor recovery after ischemic stroke. Neurorehabil Neural Repair. 2008;22:64–71. doi: 10.1177/1545968307305302
133.
Enderby P, Pandyan A, Bowen A, Hearnden D, Ashburn A, Conroy P, Logan P, Thompson C, Winter J. Accessing rehabilitation after stroke: a guessing game? Disabil Rehabil. 2017;39:709–713. doi: 10.3109/09638288.2016.1160448
134.
Holloway RG, Arnold RM, Creutzfeldt CJ, Lewis EF, Lutz BJ, McCann RM, Rabinstein AA, Saposnik G, Sheth KN, Zahuranec DB, Zipfel GJ, Zorowitz RD; on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, and Council on Clinical Cardiology. Palliative and end-of-life care in stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1887–1916. doi: 10.1161/STR.0000000000000015
135.
Switzer JA, Demaerschalk BM, Xie J, Fan L, Villa KF, Wu EQ. Cost-effectiveness of hub-and-spoke telestroke networks for the management of acute ischemic stroke from the hospitals’ perspectives. Circ Cardiovasc Qual Outcomes. 2013;6:18–26. doi: 10.1161/CIRCOUTCOMES.112.967125
136.
Schwamm LH, Holloway RG, Amarenco P, Audebert HJ, Bakas T, Chumbler NR, Handschu R, Jauch EC, Knight WA, Levine SR, Mayberg M, Meyer BC, Meyers PM, Skalabrin E, Wechsler LR; on behalf of the American Heart Association Stroke Council; Interdisciplinary Council on Peripheral Vascular Disease. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2009;40:2616–2634. doi: 10.1161/STROKEAHA.109.192360
137.
Silva GS, Farrell S, Shandra E, Viswanathan A, Schwamm LH. The status of telestroke in the United States: a survey of currently active stroke telemedicine programs. Stroke. 2012;43:2078–2085. doi: 10.1161/STROKEAHA.111.645861
138.
Milne MS, Holodinsky JK, Hill MD, Nygren A, Qiu C, Goyal M, Kamal N. Drip ‘n ship versus mothership for endovascular treatment: modeling the best transportation options for optimal outcomes. Stroke. 2017;48:791–794. doi: 10.1161/STROKEAHA.116.015321
139.
Sheth KN, Smith EE, Grau-Sepulveda MV, Kleindorfer D, Fonarow GC, Schwamm LH. Drip and ship thrombolytic therapy for acute ischemic stroke: use, temporal trends, and outcomes. Stroke. 2015;46:732–739. doi: 10.1161/STROKEAHA.114.007506
140.
Tatlisumak T, Soinila S, Kaste M. Telestroke networking offers multiple benefits beyond thrombolysis. Cerebrovasc Dis. 2009;27(suppl 4):21–27. doi: 10.1159/000213055
141.
Demaerschalk BM, Berg J, Chong BW, Gross H, Nystrom K, Adeoye O, Schwamm L, Wechsler L, Whitchurch S. American Telemedicine Association: telestroke guidelines. Telemed J E Health. 2017;23:376–389.
142.
Wechsler LR, Demaerschalk BM, Schwamm LH, Adeoye OM, Audebert HJ, Fanale CV, Hess DC, Majersik JJ, Nystrom KV, Reeves MJ, Rosamond WD, Switzer JA; on behalf of the American Heart Association Stroke Council; Council on Epidemiology and Prevention; Council on Quality of Care and Outcomes Research. Telemedicine quality and outcomes in stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48:e3–e25. doi: 10.1161/STR.0000000000000114
143.
Itrat A, Taqui A, Cerejo R, Briggs F, Cho SM, Organek N, Reimer AP, Winners S, Rasmussen P, Hussain MS, Uchino K; Cleveland Pre-Hospital Acute Stroke Treatment Group. Telemedicine in prehospital stroke evaluation and thrombolysis: taking stroke treatment to the doorstep. JAMA Neurol. 2016;73:162–168. doi: 10.1001/jamaneurol.2015.3849
144.
Chapman Smith SN, Govindarajan P, Padrick MM, Lippman JM, McMurry TL, Resler BL, Keenan K, Gunnell BS, Mehndiratta P, Chee CY, Cahill EA, Dietiker C, Cattell-Gordon DC, Smith WS, Perina DG, Solenski NJ, Worrall BB, Southerland AM; iTREAT Investigators. A low-cost, tablet-based option for prehospital neurologic assessment: the iTREAT Study. Neurology. 2016;87:19–26. doi: 10.1212/WNL.0000000000002799
145.
Belt GH, Felberg RA, Rubin J, Halperin JJ. In-transit telemedicine speeds ischemic stroke treatment: preliminary results. Stroke. 2016;47:2413–2415. doi: 10.1161/STROKEAHA.116.014270
146.
Rumsfeld JS, Brooks SC, Aufderheide TP, Leary M, Bradley SM, Nkonde-Price C, Schwamm LH, Jessup M, Ferrer JM, Merchant RM; on behalf of the American Heart Association Emergency Cardiovascular Care Committee; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Quality of Care and Outcomes Research; Council on Cardiovascular and Stroke Nursing; and Council on Epidemiology and Prevention. Use of mobile devices, social media, and crowdsourcing as digital strategies to improve emergency cardiovascular care: a scientific statement from the American Heart Association. Circulation. 2016;134:e87–e108. doi: 10.1161/CIR.0000000000000428
147.
Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O’Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245–254.
148.
Porter ME. What is value in health care? N Engl J Med. 2010;363:2477–2481. doi: 10.1056/NEJMp1011024
149.
Hannah D, Lindholm B, Maisch L. Certain uncertainty: life after stroke from the patient’s perspective. Circ Cardiovasc Qual Outcomes. 2014;7:968–969. doi: 10.1161/CIRCOUTCOMES.114.001315
150.
Chaisinanunkul N, Adeoye O, Lewis RJ, Grotta JC, Broderick J, Jovin TG, Nogueira RG, Elm JJ, Graves T, Berry S, Lees KR, Barreto AD, Saver JL; DAWN Trial and MOST Trial Steering Committees. Adopting a patient-centered approach to primary outcome analysis of acute stroke trials using a utility-weighted modified Rankin Scale. Stroke. 2015;46:2238–2243. doi: 10.1161/STROKEAHA.114.008547
151.
Duncan PW, Bode RK, Min Lai S, Perera S; Glycine Antagonist in Neuroprotection Americans Investigators. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Arch Phys Med Rehabil. 2003;84:950–963.
152.
Williams LS, Weinberger M, Harris LE, Clark DO, Biller J. Development of a stroke-specific quality of life scale. Stroke. 1999;30:1362–1369.
153.
Yin S, Njai R, Barker L, Siegel PZ, Liao Y. Summarizing health-related quality of life (HRQOL): development and testing of a one-factor model. Popul Health Metr. 2016;14:22. doi: 10.1186/s12963-016-0091-3
154.
EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
155.
Parker C, Schwamm LH, Fonarow GC, Smith EE, Reeves MJ. Stroke quality metrics: systematic reviews of the relationships to patient-centered outcomes and impact of public reporting. Stroke. 2012;43:155–162. doi: 10.1161/STROKEAHA.111.635011
156.
Solomon NA, Glick HA, Russo CJ, Lee J, Schulman KA. Patient preferences for stroke outcomes. Stroke. 1994;25:1721–1725.
157.
Patient-Reported Outcomes Measures Group, Oxford. Report to the Department of Health: a structured review of patient-reported outcome measures in relation to stroke. 2009. http://phi.uhce.ox.ac.uk/pdf/PROMs_Oxford_Stroke_17092010.pdf. Accessed August 1, 2014.
158.
American Heart Association/American Stroke Association. ICHOM Standard Set for Stroke. http://www.ichom.org/medical-conditions/stroke. Accessed July 28, 2018.
159.
Salinas J, Sprinkhuizen SM, Ackerson T, Bernhardt J, Davie C, George MG, Gething S, Kelly AG, Lindsay P, Liu L, Martins SC, Morgan L, Norrving B, Ribbers GM, Silver FL, Smith EE, Williams LS, Schwamm LH. An international standard set of patient-centered outcome measures after stroke. Stroke. 2016;47:180–186. doi: 10.1161/STROKEAHA.115.010898
160.
Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, Amtmann D, Bode R, Buysse D, Choi S, Cook K, Devellis R, DeWalt D, Fries JF, Gershon R, Hahn EA, Lai JS, Pilkonis P, Revicki D, Rose M, Weinfurt K, Hays R; PROMIS Cooperative Group. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010;63:1179–1194. doi: 10.1016/j.jclinepi.2010.04.011
161.
Revicki DA, Kawata AK, Harnam N, Chen WH, Hays RD, Cella D. Predicting EuroQol (EQ-5D) scores from the Patient-Reported Outcomes Measurement Information System (PROMIS) global items and domain item banks in a United States sample. Qual Life Res. 2009;18:783–791. doi: 10.1007/s11136-009-9489-8
162.
Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. Adverse drug events occurring following hospital discharge. J Gen Intern Med. 2005;20:317–323. doi: 10.1111/j.1525-1497.2005.30390.x
163.
Miller, ME, Senate, U. Report to the Congress: Reforming the Delivery System. Washington, DC: Medicare Payment Advisory Commission; 2008.
164.
Solet DJ, Norvell JM, Rutan GH, Frankel RM. Lost in translation: challenges and opportunities in physician-to-physician communication during patient handoffs. Acad Med. 2005;80:1094–1099.
165.
Reeves MJ, Hughes AK, Woodward AT, Freddolino PP, Coursaris CK, Swierenga SJ, Schwamm LH, Fritz MC. Improving transitions in acute stroke patients discharged to home: the Michigan Stroke Transitions Trial (MISTT) protocol. BMC Neurol. 2017;17:115. doi: 10.1186/s12883-017-0895-1
166.
Stroke Treatment and Ongoing Prevention Act of 2001, HR 3431, 107th Cong (2001).
167.
Furthering Access to Stroke Telemedicine Act of 2017, HR 1148, 115th Cong (2017).
168.
Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017, S 870, 115th Cong (2017).
169.
Owens S. States increasingly pass legislation to promote stratifying levels of stroke care, but challenges remain. Neurol Today. 2016;16:16–22.
170.
Prabhakaran S, O’Neill K, Stein-Spencer L, Walter J, Alberts MJ. Prehospital triage to primary stroke centers and rate of stroke thrombolysis. JAMA Neurol. 2013;70:1126–1132. doi: 10.1001/jamaneurol.2013.293
171.
James ML, Grau-Sepulveda MV, Olson DM, Smith EE, Hernandez AF, Peterson ED, Schwamm LH, Bhatt DL, Fonarow GC. Insurance status and outcome after intracerebral hemorrhage: findings from Get With The Guidelines-Stroke. J Stroke Cerebrovasc Dis. 2014;23:283–292. doi: 10.1016/j.jstrokecerebrovasdis.2013.02.016
172.
Robeznieks A. Physicians protest harmful Anthem emergency care coverage policy. AMA Wire. 2017. https://wire.ama-assn.org/practice-management/physicians-protest-harmful-anthem-emergency-care-coverage-policy. Accessed September 30, 2017.
173.
Fox M. Major insurance company’s payment decision angers ER doctors. NBC News. 2017. https://www.nbcnews.com/health/health-news/major-insurance-company-s-payment-decision-angers-er-doctors-n767766. Accessed September 30, 2017.
Information & Authors
Information
Published In
Copyright
© 2019 American Heart Association, Inc.
Versions
You are viewing the most recent version of this article.
History
Published online: 20 May 2019
Published in print: July 2019
Keywords
Subjects
Authors
Disclosures
Writing Group Member | Employment | Research Grant | Other Research Support | Speakers’ Bureau/Honoraria | Expert Witness | Ownership Interest | Consultant/Advisory Board | Other |
---|---|---|---|---|---|---|---|---|
Opeolu Adeoye | University of Cincinnati | None | None | None | None | None | None | None |
Mark J. Alberts | Hartford HealthCare Neurosciences Institute | None | None | None | None | None | The Joint Commission* | None |
William G. Barsan | University of Michigan | None | None | None | None | None | None | None |
Cheryl Bushnell | Wake Forest Baptist Comprehensive Stroke Center | None | None | None | None | None | None | None |
Edward C. Jauch | University of South Carolina | BASE Study, ischemia care (principal investigator)*; Executive Committee, PRISMS study, Genentech*; Executive Committee, POSITIVE trial, Penumbra, Medtronic* | None | None | None | None | Chair, South Carolina Department of Health Stroke Advisory Council* | None |
Alexander A. Khalessi | UC San Diego | None | None | None | None | None | None | None |
Jean Luciano | University of Pennsylvania | None | None | None | None | None | None | None |
Raul G. Nogueira | Emory University | None | None | None | None | None | None | None |
Karin V. Nyström | Yale Stroke Center | None | None | None | None | None | None | None |
Peter Panagos | Washington University | None | None | None | None | None | None | None |
Lee H. Schwamm | Massachusetts General Hospital | None | None | None | None | None | Expert consultant to CMS on measure design (via subcontract with YALE-CORE)* | AHA leadership of GWTG–Stroke, HASC Science Committee, ML Stroke. Membership on JC CSC and PSC expert panels* |
A. Colby Tiner | American Heart Association | None | None | None | None | None | None | None |
Dileep R. Yavagal | University of Miami Miller School of Medicine | None | None | None | None | None | Cerenovous, Consultant* Deck Therapeutics, Consultant*; GLG Consulting, Consultant*; Guidepoint Consulting, Consultant*; Inneuroco, Inc, Consultant*; Medtronic, Consultant and Member of Clinical Trial Steering Committee for SWIFT-PRIME*; Mosaic Consulting, Consultant*; Neuralanalytics Poseydon Medical, LLC, Medical Advisory Board*; Rapid Medical, Consultant and Steering Committee Member of the TIGER trial*; Vascular Dynamics, Consultant and Steering Committee Member of the CALM-2 trial* | None |
Richard D. Zorowitz | MedStar National Rehabilitation Network, Georgetown University | None | None | None | None | None | None | None |
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
*
Modest.
Reviewer | Employment | Research Grant | Other Research Support | Speakers’ Bureau/Honoraria | Expert Witness | Ownership Interest | Consultant/Advisory Board | Other |
---|---|---|---|---|---|---|---|---|
Jeffrey L. Saver | UCLA | None | None | None | None | None | Medtronic*; Stryker*; Neuravi*; Boehringer Ingelheim*; St. Jude Medical* | None |
Joel Stein | Columbia University | None | None | None | None | None | None | None |
Namvar Zohoori | Arkansas Department of Health | None | None | None | None | None | None | None |
This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
*
Modest.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Stroke Mortality and Stroke Hospitalizations: Racial Differences and Similarities in the Geographic Patterns of High Burden Communities Among Older Adults, Preventing Chronic Disease, 21, (2024).https://doi.org/10.5888/pcd21.230339
- Effects of the Nurse-led Program on Disability Improvement in Patients with Stroke: A Systematic Review and Meta-analysis, Journal of Disability Research, 3, 2, (2024).https://doi.org/10.57197/JDR-2024-0014
- Improving the organization of specialized and high-tech medical care for patients with acute cerebral circulatory disorders on the example of the Almaty region, Salud, Ciencia y Tecnología, 4, (2024).https://doi.org/10.56294/saludcyt2024.583
- Stroke rehabilitation: from diagnosis to therapy, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1402729
- Exploring the causal factor effects of hypothyroidism on ischemic stroke: a two-sample Mendelian randomization study, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1322472
- Endovascular Thrombectomy for Acute Ischemic Stroke in Indonesia: Challenging and Strategic Planning, Neuropsychiatric Disease and Treatment, Volume 20, (621-630), (2024).https://doi.org/10.2147/NDT.S453629
- Getting the message across; a realist study of the role of communication and information exchange processes in delivering stroke Early Supported Discharge services in England, PLOS ONE, 19, 3, (e0298140), (2024).https://doi.org/10.1371/journal.pone.0298140
- Differences in Receipt of Neurologist Evaluation During Hospitalization for Ischemic Stroke by Race, Sex, Age, and Region, Neurology, 102, 7, (2024).https://doi.org/10.1212/WNL.0000000000209200
- A hybrid strategy using an ambulance and a helicopter to convey thrombectomy candidates to definite care: a prospective observational study, BMC Emergency Medicine, 24, 1, (2024).https://doi.org/10.1186/s12873-024-00931-0
- Perispinal Etanercept to improve STroke Outcomes (PESTO): Protocol for a multicenter, international, randomized placebo-controlled trial, European Stroke Journal, 9, 3, (789-795), (2024).https://doi.org/10.1177/23969873241249248
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.